Establishment and characterization of several liver cell lines as tools for the study of physio-pathological cellular interplay by Costa, Viviana
 1 
 
 
 
 
 
 
 
Establishment and characterization of several liver cell 
lines as tools for the study of 
 physio-pathological cellular interplay 
 
 
 
 
 
 
 
Dr.ssa Viviana Costa 
 
 
 
 
 
 
 
 
 
 
Doctoral School “Science Pasteuriane” 
Biology and Molecular Medicine 
XXV ciclo 
 2 
 
 
Establishment and characterization of several liver cell lines as tools for the 
study of physio-pathological cellular interplay 
 
Candidate: Costa Viviana 
Academic year 2011-2012 
XXV cycle 
 
Ph.D. program: “BIOLOGY AND MOLECULAR MEDICINE” 
Department of Cellular Biotechnology and Hematology, “Sapienza” University    of Rome 
 
Director of doctoral program:  
Prof. Marco Tripodi 
Department of Cellular Biotechnology and Hematology, “Sapienza” University of Rome 
 
Scientific Tutor: 
Prof. Marco Tripodi  
Department of Cellular Biotechnology and Hematology, “Sapienza” University of Rome 
 
Board of examiners: 
 
Prof. Diego Di Bernardo 
“Federico II” University of Naples 
 
Prof. Alessandro Aiuti 
“Tor Vergata” University of Rome 
 
Prof.ssa Livia Leoni 
“Roma Tre” University of Rome 
 
 
  
 3 
 
INDEX 
 
Abstract           pag 6 
Abbreviations           pag 9 
 
Introduction 
 
1. Chapter 1: Liver Functions and Regeneration     pag 10 
 
1.1  Liver Anatomy and Physiology       pag 10 
1.2  Liver regeneration             pag 13 
1.3  Hepatocytes and regeneration       pag 14 
1.3.1 Hepatocytes and regeneration                               pag 17 
1.4    Sinusoidal Endothelial        pag 20 
1.4.1 Sinusoidal endothelial cells (SECs) and regeneration                pag 22 
1.5    Hepatic Stellate cells (HSCs)       pag 24 
1.5.1 HSCs and regeneration       pag 25 
1.6    Liver progenitor cells        pag 27 
1.6.1 Liver progenitor cells and regeneration     pag 28 
1.7    Liver Tissue engineering           pag 32 
1.8    Bioartificial liver devices         pag 34 
1.9    Cell sourcing          pag 36 
 
 
2. Chapter 2: Aims of work and Cellular Models      pag 40 
 
2.1 Aims of the work         pag 40 
2.2 Met Murine Hepatocytes: MMH soluble factors are able  
to maintain sinusoidal endothelial cells in differentiate state.   pag 42 
2.3 Murine Resident Liver Stem Cells (RLSCs)        pag 44 
 
 
 4 
 
 
3. Chapter 3: Materials and Methods      pag 45 
 
3.1 In vitro studies         pag 45 
Primary culture 
Immortalization strategies 
Adenoviral transduction of Cell Culture 
Single cell cloning 
3.2 In vivo Studies            pag 46 
Animals care and treatment 
Heterotopic Transplants  
Orthotopic transplants  
3.3 Cell and tissue analysis          pag 47 
RNA extraction, Reverse Transcription and Real Time 
quantitative PCR (qRT-PCR) 
               Immunofluorescence 
               Flow cytometry 
               Tube formation assay 
               SEM analysis  
 
 
4. Chapter 4: Results         pag 51 
 
4.1 RLSC co-express epithelial and mesenchymal markers  
and undergo into mutually exclusive differentiations      pag 51 
4.2 RLSC derivatives display liver-specific epithelial and 
mesenchymal phenotypes in orthotopic transplant     pag 55 
4.3 RLSC give rise to  liver-specific epithelial and 
mesenchymal derivatives in heterotopic transplants    pag 57 
 
 
 
 5 
 
5. Chapter 5: Results         pag 59 
 
5.1 Characterization of elutriated non parenchymal cells (NPC)   pag 59 
5.2 Establishment and characterization of NPC     pag 60 
5.3 Establishment and characterization 
of clonal endothelial cell lines       pag 62 
5.4 Liver sinusoidal endothelial cells are to maintain  
the differentiate state in vitro       pag 68 
5.5 MLECs forms sinusoids  in Orthotopic Transplants    pag 70 
 
 
 
6. Chapter 6: Discussion         pag 73 
 
7. References           pag 76 
 
8. Acknolgment           pag 83 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 6 
 
Abstract 
 
Establishment and characterization of  cell lines as tools for the study of physio-
pathological liver cellular interplay 
 
The liver is the largest internal organ of the body, constituting approximately 2% to 5% of 
body weight in the adult and 5% in the neonate. This organ plays a central role in metabolic 
homeostasis and it is responsible for the synthesis, storage and redistribution of nutrients, 
carbohydrates, fats and vitamins. The liver has a peculiar and fascinating ability: it is able to 
regenerate itself after loss of parenchyma for surgical resection or injury caused by drugs, 
toxins or acute viral disease. 
Considering the variety of liver functions, it is not surprising that a large number of cell 
types and cell–cell interactions are required for its functionality. Most of the liver functions 
are carried out by the hepatocytes (about 70-75% of hepatic cells); these, together with 
cholangiocytes (10-5 %), both of endodermal derivation, constitute the hepatic parenchyma. 
The other 20% made up of non-parenchymal cells, includes: 1) Kupffer cells, essential for 
the phagocytosis of foreign particles as well as for the cytokines production, 2) stellate cells, 
that store vitamin A and produce extra-cellular matrix (ECM) components, 3) sinusoidal 
endothelial cells, that line the hepatic sinusoids providing a large surface for nutrients 
absorption and 4) lymphocytes, that mediate adaptive immune responses.  
A unique architectural arrangement of hepatic parenchymal and non-parenchymal cells 
governs liver functionality.  
The need to regenerate functional liver tissue in vitro is well established in three areas of 
application: model tissue for drug testing, bio artificial liver supports, and potentially 
engineered organs for implantation into patients. The ability of the mammalian liver to 
regenerate in vivo indicates that within correct stimulatory environment it should be 
possible to grow large quantities of liver tissue in vitro. 
Our interest is always been to understand the minimal environmental signals that are 
required to generate liver tissue that is able to perform a physiological cellular interplay with 
parenchymal and non-parenchymal cells. For these reasons, we performed different cellular 
models. 
We previously described the identification and characterization of an immortalized 
bipotential precursor cell within the MMH lines. MMHs (from Met murine hepatocyte) are 
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immortalized and untransformed  cell lines derived from explants
 
of liver derived from 
transgenic
 
mice expressing a constitutively active truncated human Met receptor
 
(cyto-Met) 
under control of the human 1-antitrypsin transcription
 
unit. MMH lines present an 
epithelial cell polarity and the expression of hepatic functions. We used the MMHs model 
for the study: Hepatocyte transformation; Liver differentiation and transdifferentiation 
(EMT); Cholesterol metabolism; Retinol binding protein regulated secretions; Hemopoiesis 
and Hepatic influence of HSC.  
In addition, we previously isolated characterized a number of stable liver stem cell lines 
named RLSCs (from resident liver stem cells) that spontaneously acquire an epithelial 
morphology and differentiate into  hepatocyte named RLSCdH (from RLSC derived 
Hepatocytes). Thanks to this model we understood the hepatocyte post-differentiative 
patterning define “zonation”: their spontaneous differentiation, in fact, generates periportal 
hepatocytes that may be induced to switch into perivenular hepatocytes by means of the 
convergence of Wnt signalling on the HNF4-driven transcription. Recently, we 
demonstrate that RLSCs are able to differentiate in vivo (orthotopic transplants and 
heterotopic transplants) in epithelial and mesenchymal derivatives. Our data suggesting, for 
the first time, the existence of an adult stem/precursor cell capable of providing both 
parenchymal and non-parenchymal components to a complex epithelial organ.  
For the study of environment signals necessary to liver regeneration in vitro, is necessary 
the presence of sinusoidal endothelial cellular model. In fact, liver endothelium is a prime 
example of organ-specific microvascular differentiation and functions. 
The liver sinusoidal endothelial (LSECs) cells are a morphologically and functionally 
unique sub-population of liver endothelial cells that form the lining of the hepatic sinusoids. 
They possess fenestrations that are approximately 50–150 nm in diameter and most are 
aggregated into groups of 10–100, so-called liver sieve plates. The diameter and number of 
fenestrations are altered by various liver diseases, diabetes mellitus and old age and are 
influenced by cytokines and hormones . Alteration in the size and number of fenestrations 
influences the hepatic trafficking of lipoproteins , clearance of pharmaceutical agents , liver 
regeneration and interactions between lymphocytes and hepatocytes.  Decapillarization is a 
dedifferentiation process that occurs in vitro over time with SEC in culture. Determinants of 
endothelial cell phenotype include heterotypic contact with pericytes or smooth muscle 
cells, paracrine effects of epithelial cells, shear stress, and the underlying substratum. Little 
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is known about the determinants of the normal SEC phenotype. Proximity to liver tissue can 
induce the SEC phenotype, but the pathways that regulate this have not been established. 
This is because endothelial primary cells are generally difficult and time–consuming to 
isolate, limited in number, invariably contain impurities with other cell types, and may lack 
the features of pathologic vasculature. For these reasons, many authors performed different 
immortalization strategies on freshly isolated SECs (immortalization with SV40 Middle T 
or Large T antigens) to obtain a cellular model for the study endothelial-specific functions. 
Nevertheless these approaches can induce activation of endothelial- specific pathways in 
aberrant way. 
Object  
The current study is aimed to obtain an sinusoidal endothelial cell line as in vitro system for 
the identification of critical microenvironment factors involved in liver cellular interplay 
during physiology or pathology conditions. We hypothesis to improve protocols of liver 
tissue engineering using the our cellular models. 
Results 
The current study  to go beyond the limits for maintaining LSECs in vitro, thanks the effects 
of soluble factors released by MMH lines (“Met Murine Hepatocytes” cells are 
immortalised and untransformed hepatocyte) on  the sinusoidal endothelial cells phenotype 
in vitro and in vivo. Thanks hapatocytes soluble factors, we are able to obtain a 
“spontaneously immortalized murine liver sinusoidal endothelial cells line”. In fact, 
Hepatocyte Conditioned medium was able to promote a substantial expansion of sinusoidal 
endothelial cells and their differentiation phenotype. 
In Orthotopic transplants MLECs show an intrinsic capability to organize in physiological 
way and are able to maintain a differentiation state.  Also, MLECs are able to promote 
cellular interplay between parenchymal and non-parenchymal cells, as shown by a sub-
endothelial localization of pericyte, in proximity of sinusoids performed by MLECs. 
In vitro studies showed that MLECs cultured with hepatocyte soluble factors, maintained 
the greatest degree of differentiation, as showed by high levels of endothelial cells markers 
expression, such as CD105, CD144, MECA32, VEGFR2. Also, MLECs are able to organize 
in tube-like structures on matrigel-coat as in vivo. It’s induced that the maintenance of cell 
phenotype is dependent on micro environmental signals such as paracrine interactions (cell–
cell), physical-chemical factors (oxygen tension, metabolites), mechanical stimuli, and cell–
extracellular matrix (ECM) interaction. 
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Highlights these data suggest that MMH, RLSCs and MLECs are models that permit:   
-the study of molecular bases of cellular interplay in physiology and pathology; 
-to improve protocols of liver tissue engineering. 
 
Abbreviations: 
SECs/LSECs: sinusoidal/Liver sinusoidal endothelial cells; HSC: hepatic stellate cells; 
MMH: Met murine hepatocyte; RLSCs: resident liver stem cells; MH-CM: hepatocyte 
conditional medium; EGM 2:endothelial instructive medium. 
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Introductions 
Chapter 1: Liver Functions and Regeneration 
 
1.1 Liver Anatomy and Physiology  (Liver functional Unit-Acinus) 
 
The liver is a versatile organ which plays an important role in a variety of critical functions, 
including the efficient uptake of amino acids, carboydrates, bile acids, cholesterol, proteins, 
lipids and vitamins for storage and metabolism subsequent to release into bile and /or blood. 
The classical structural unit of the liver is the hepatic lobule (Figure 1). 
The boundaries of the classical lobules are defined by connective tissue septa from the 
capsule.  When viewed in cross section, the lobule has the shape of a polygon, usually a 
hexagon .The angles of the hexagon are called portal areas (or portal canals, or portal tracts). 
The liver cells are arranged in stacks of anastomosing plates, one or two cells thick, 
radiating from a central vein at the centre of the lobule towards the periphery to define the 
basic functional unit of the liver, known as the acinus which also serves as a microcosm of 
the major hepatic microenvironments, containing the essential cellular and physiological 
features that define the unique architecture of the liver 
tissue.  
 
 
 
 
 
 
 
Figure 1. Representation of histotypic liver microstructure. (A) Diagram of the basic 
hepatic lobule and acinus substructure showing the relative direction of blood flow from 
portal triads towards the central veins (red arrows). (B) Diagram illustrating the three-
dimensional architecture of the liver between a portal triad and the central vein. The 
networks of bile canaliculi (yellow-green) run parallel and counter to the blood flow 
through the sinusoids. 
 
 Figure by LeCluyse E.L et al.,Critical review in tossicology,2012. 
 
Hepatic plates or cords are generally one hepatocyte 
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thick and are separated from one another by the hepatic sinusoids (the “capillaries” of the 
liver) which are lined by sinusoidal endothelium. 
The liver microanatomy is based on the concept of the liver lobule, which is polyhedral 
(hexagonal) prism of liver tissue, with a terminal hepatic venule at the center and rimmed by 
6 portal tracts at the angles of a hexagon. 
The lobule unit reference is used to describe the zonation of hepatocyte functions precise 
location of injury and other processes. The liver acinus is demarcated into three discrete 
zones: zone 1 is the periportal region; zone 2 is the midlobular region; and zone 3 is the 
pericentral region. Periportal hepatocytes cells are the first to regenerate. Midzonal (half-
way between the portal tracts and  central vein) hepatocytes receive blood that has less 
oxygen, toxins,etc. than periportal hepatocytes. Centrilobular hepatocytes, or hepatocytes 
surrounding the central veins, are most susceptible to ischemic insults and contain drug 
metabolizing. Blood enters the liver from the portal veins and hepatic arteries at the portal 
triads, flows through the sinusoidal microvasculature surrounded by the plates of 
parenchymal cells, and exits from the central vein. Due to the particular configuration of 
cells along the microvasculature and the directionality of flow through the lobular units, 
various chemical gradients and microenvironments are present. (Figure 2). Hepatocytes are 
exposed to gradients of nutrients and waste products leading to zonal metabolic 
specialization and zonal variation in susceptibility to ischemia and drug toxicity. 
Different zones have different metabolic responsibilities, such as endogenous substrate 
utilization, oxygen tension, gene expression and xenobiotic clearance mechanisms.  
Specific enzymatic/metabolic activities, i.e. carbohydrate metabolism, ammonia 
detoxification, bile formation/transport/secretion and drug biotransformation, are confined 
to the perivenular (PV, i.e. near the centrolobular vein) or periportal (PP, i.e. near the portal 
vein) zones of the hepatic lobule (41). 
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Figure 2.Structural and functional zonation of the liver. (A) Discrete zones of the liver between the portal vein (PV) and 
central vein (CV) illustrating the differences in cell size, phenotype and gradients in oxygen tension and metabolism.  
In figure to right, is  described hepatocytes metabolic zonation 
Figure 2A by LeCluyse E.L et al.,Critical review in tossicology, 2012, and Figure 2B by Williams P.D. et al., 2013. 
 
 
The liver is comprised of cells that are broadly into two categories: parenchymal cells and 
non-parenchymal cells (NPC). Hepatocytes are the most numerous and comprise 60% of the 
total cells and 80% of the volume of the liver. Sinusoidal endothelial cells (SECs), Kupffer 
cells, hepatic stellate cells (HSC), and biliary epithelium make up a significant number (3-
20% each) of the remaining biologically important cells. Hepatocytes are arranged in plates 
or laminae of cords 1 cell thick (called muralium) that branch and anastomose in a 
continuous labrynth with limiting plates being at the capsule and portal regions. The 6 or 
more surfaces of the hapatocyte either abut adjacent parenchymal cells, border bile 
canaliculi, or are exposed to the perisinusoidal space (this surface being covered by 
microvilli). Being the workhorses of the liver, hepatocytes contain the machinery necessary 
to carry out the thousands of vital functions (44). 
Biliary epithelium primarily acts as a lining of the conduit for bile flow but it also modifies 
canalicular bile and concentrates bile in the gall bladder. Biliary epithelia are “effective 
communicators” with neighboring cells in producing mediators that are involved in cell 
growth and response to injury. 
The sinusoidal endothelial cells (SECs) are the primary barrier between blood and 
hepatocytes and they act to filter fluids, solutes, and particles between the blood and space 
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of Disse and represent up to 20% of the liver cells. SECs are unique type of endothelial cells 
in that they have fenestrae, lack a basal lamina, and can transfer molecules and particles by 
endocytosis. Blood cells pass through sinusoids that gently “massage” fluids though 
fenestrae and, being dynamically active, it is not surprising that SECs contain extensive 
cytoskeletal support. For these particular functions, SECs are involved in different liver 
disease. 
Kupffer cells represent 15% of the liver cells (30% of sinusoidal cells) and are derived from 
circulating monocytes. They can proliferate locally, are phagocytic, are the, major producers 
of cytokines as mediators of inflammation and provide “cross-talk” with other cells. Hepatic 
stellate cells (HSC) comprise about 5% of liver cells and were previously called Ito cells or 
fat-storing cells. HSC normally produce extracellular matrix, control microvascular tone, 
store and metabolize vitamin A and lipid, and when actived transform to myofibroblasts. In 
the activated myofibroblast form, they typically express desmin and smooth muscle actin 
filaments. 
The extracellular matrix (ECM) is important in the regulation and modulation of hepatic 
function. Five to 10% of the liver is collagen. The ECM has numerous components 
including matrix metalloproteinases; the glycoproteins, laminin, fibronectin, vitronectin, 
undulin, nidogen (entactin); and proteoglicans such heparin sulphate. 
 
 
1.2 Liver regeneration 
 
The liver has a peculiar and fascinating ability: it is able to regenerate itself after loss of 
parenchyma for surgical resection or injury caused by drugs, toxins or acute viral disease. 
The ancient myth of Prometheus highlighted this capability: the Titan Prometheus was 
bound for ever to a rock as punishment by Zeus for his theft of the fire; each day great eagle 
ate his liver and each night the liver was regenerated, only to be eaten again the next day. 
The liver compensatory regeneration is a rapid and tightly orchestrated phenomenon 
efficiently ensuring the reacquisition of the original tissue mass and its functionality. 
Primarily, it involves the re-entry into cell-cycle of parenchymal hepatocytes which are able 
to completely recover the original liver mass (27). The liver anatomical and functional units 
reconstitution also requires non parenchymal cells (sinusoidal endothelial cells, 
cholangiocyte, Kuppfer cells, stellate cells). It is yet not clear if each cell histotype is 
 14 
 
involved in the proliferative process or if the regeneration requires the activity of a cell with 
multiple differentiations potential. Recently, the bipotentiality of hepatocytes, able to divide 
giving rise to both hepatocytes and cholangiocytes, has been suggested. Furthermore, when 
injury is severe or the hepatocytes can no longer proliferate a progenitor cell population, 
normally a quiescent compartment is activated. A population of a small portal cells named 
“oval cells” is indicated a heterogeneous population of bipotent transient ampliflying cells, 
originating from Canale of Hering (16). These cells are normally quiescent but, after injury, 
rapidly and extensively proliferate and differentiate in hepatocytes and cholangyocites . 
The observation that oval cells are mixed precursor population suggests their differentiation 
from liver stem cells (67). Since the hepatocytes are able to regenerate themselves to 
compensate liver mass loss, the existence of a liver stem cells, able to drive regeneration in 
conditions of extreme toxicity affecting the same hepatocytes, has long been debated. 
Today, there is growing evidence that the liver stem cell exists and its isolation from the 
organ, its numerical expansion in vitro and its characterization are joint effectors in many 
laboratories. The interest of the scientific community in the identifications, isolation and 
manipulation of the hepatic stem cell also depends on the fact that the great hopes placed in 
the use of mature hepatocytes in cell transplantation protocols for the treatment of liver 
disease have been disappointed. The basis of these unsatisfactory therapeutic approaches lie 
in the paradox, not yet resolved, of the inability of hepatocytes, which show in vivo a 
virtually unlimited proliferative potential, to grow in vitro to quantitatively and qualitatively 
amount suitable for cell transplantation in adults 
 
 
1.3 Hepatocytes  
 
The parenchymal cells or hepatocytes are highly differentiated epithelial cells that comprise 
the cell plates of the liver lobule (Figure 4). They perform a majority of the physiological 
functions commonly associated with the liver, including xenobiotic biotransformation and 
elimination. Hepatocytes are involved in protein, steroid, and fat metabolism as well as 
vitamin, iron, and sugar storage and display marked morphologic, biochemical and 
functional heterogeneity based on their zonal location. Under healthy non adaptive 
conditions, parenchymal cell size increases from Zone 1 to Zone 3, accompanied by 
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distinctive zonal variations in morphological features of the cells, such as mitochondria, 
endoplasmic reticulum, lipid vesicles and glycogen granules (Figure 2A). 
Much of the functional diversity of hepatocytes is also revealed in their cytological features. 
Hepatocytes are cuboidal in shape and possess one or more nuclei with prominent nucleoli 
(Figure 4). The fraction of hepatocytes that are polyploid (4N and 8N), which results from 
mitotic division of the nucleus without accompanying cytokinesis, increases across the liver 
lobule from Zone 1 to Zone 3. Generally, hepatocytes possess abundant mitochondria with 
Golgi complexes localized mainly adjacent to the bile canaliculi. The cytoplasm is rich in 
both rough endoplasmic reticulum (RER), which is indicative of the hepatocyte’s secretory 
nature, and smooth endoplasmic reticulum (SER), with many of the enzymes involved in 
phase 1 and 2 biotransformation of drugs and other xenobiotics. Lysosomes are scattered 
throughout the cytoplasm and play a central role in the degradation of extracellular and 
intracellular macromolecules including organelles and proteins (autophagy) that results from 
environmental stress, such as nutrient or serum deprivation. 
Hepatocytes are also highly polarized cells with distinct sinusoidal and canalicular 
junctional complexes. These membrane domains exhibit ultrastructural, compositional, and 
functional differences and are essential for the hepatocyte’s role in the uptake, metabolism, 
and biliary elimination of both endogenous and exogenous substrates(45). 
In the intact liver, hepatocytes exhibit efficient transport of a wide variety of endogenous 
and exogenous substances from blood into bile. Physiologically, biliary transport is 
concerned primarily with the production and secretion of bile components which are 
necessary for fat absorption in the gut but is also an important step in the detoxication of 
both endogenous and exogenous compounds. The production of bile requires the 
coordinated participation of transport mechanisms selectively localized to the sinusoidal and 
canalicular membranes of the hepatocytes. Perturbation of these transport mechanisms by 
drugs and other xenobiotics is one cause of intrahepatic cholestasis that can lead to 
accumulation of substrates to toxic levels in both the liver and plasma. 
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Figure 4. Histological and architectural structure of the liver parenchyma and endothelium. (A) Transmission electron micrograph of 
whole liver showing histotypic configuration and cytoarchitecture of hepatocytes (HC), including bile canaliculi (BC) and nucleoli (arrowhead). 
Sinusoids contain red blood cells (RBC) and resident macrophages (Kupffer cells, KC), and are lined with sinusoidal endothelial cells 
(LSEC).(B) Diagram illustrating the diverse morphological features of the mature hepatocyte including bile canaliculi, junctional complexes, and 
various subcellular organelles. Hepatocytes exhibit cellular polarity of subcellular organelles, cytoskeletal elements, and biochemical 
composition of membrane domains. BLD, basolateral domain; AD, apical domain; RER, rough endoplasmic reticulum; SER, smooth 
endoplasmic reticulum; Mito, mitochondria; Gly, glycogen granules; Lys, lysosomes; Sp Disse, space of Disse; Fen, fenestrations; ECM, 
extracellular matrix; GJIC, gap junction intercellular communication; Desm, desmosome; AJ, adherence junction; TJ, tight junction; BC, bile 
canaliculi; LSEC, liver sinusoidal endothelial cell. 
Figure by LeCluyse E.L et al.,Critical review in tossicology,2012. 
 
 
The functional and structural specialization of the hepatocyte is related to selective 
activation and the sustained expression of a distinct set of gene programs encoding specific 
categories of proteins. The expression of hepatocyte-specific genes is primarily regulated at 
the transcriptional level and depends on signals from both inside and outside the cell.  
Extracellular soluble (e.g. growth factors, cytokines, other hormones) and insoluble (e.g. 
extracellular matrix composition) signals play a major role in determining which 
combination of genes is expressed. 
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1.3.1 Hepatocytes and regeneration 
 
Regeneration of the original liver mass after damage has been extensively studied in rodents 
after two-thirds partial hepatectomy (PH) (9). Regeneration of the liver depends on both 
hyperplasia and hypertrophy of the hepatocytes, cells that in a normal adult liver exhibit a 
quiescent phenotype. Hypertrophy begins within hours after PH then hyperplasia follows 
(65). This occurs first in the periportal region of the liver lobule then spreads toward the 
pericentral region. 
The restoration of liver volume depends on three steps involving the hepatocytes: i) 
initiation, ii) proliferation and iii) termination phases. 
The initiation steps depends on the “priming” of parenchymal cells, mainly via the signaling 
pathways triggered by cytokines IL-6 and TNF-secreted by Kuppfer cells, rendering the 
hepatocytes sensitive to growth factors and competent to replication. 
After the G0/G1 transition in the initiation phase, the hepatocytes will enter into the cell 
cycle (Figure 3) (65). Growth factors, primarily HGF, epidermal growth factors (EGF) and 
TGF-are responsible of this second steps of regeneration in which the hepatocytes both 
proliferate and grown in cell size, activating the IL6/STAT 3 and PI3/PDX1/Akt pathways 
respectively. The fist signaling cascade regulates the cyclin D1/p21 and also protects against 
cell death, for example by up-regulation FLIP, Bcl 2 and Bcl-XL. The latter pathway 
regulates cell size via mammalian target of rapamycin (mTOR) (28;64;58;31). Numerous 
growth factors (for example HGF, TGF-EGF, glucagon, insulin and cytokines like TNF, 
IL-1, IL-6 and somatostatin (SOM) are implicated in the regeneration process. 
The HGF is a potent growth factors mainly acting on hepatocytes in a paracrine manner 
binding to its specific trans-membrane receptor tyrosine kinase c-met. HGF is secreted as an 
inactive precursor and stored in the extracellular matrix (ECM), then activated by the 
fibrinolitc system (38). The HGF/met signaling is transduced to its downstream mediators, 
i.e. the Ras-Raf- MEK, ERK 1/ 2 (7), PI3K/PDX1/Akt (55) m TOR/S6 kinase pathway, 
resulting in cell cycle progression. 
TGF-is another growth factor relevant in liver regeneration (70). It belongs to the EGF 
family, of which all members (EGF, heparin binding EGF-like factor and amphiregulin) 
transduce trough the common receptor EGF receptor (EGFR) and exert overlapping 
functions (26). This factor acts in autocrine and paracrine fashions and its production and 
secretion are induced by HGF. IL-6 induces mitotic signals in hepatocytes through the 
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activation of STAT-3 (18) The IL-6/STAT-3 signaling involves several proteins: the IL-6 
receptor, gp130, receptor-associated Janus kinase (Jak) and STAT-3. The IL-6 receptor is in 
a complex with gp130, which, after recognition by IL-6, transmits the signal. Jak is 
responsible of gp130 and STAT-3 activation after IL-6 binding. The STAT-3 form released 
by gp130 dimerizes and translocates to the nucleus to activate the transcription. STAT3 
controls cell cycle progression from G1 to S phase regulating the expression of cyclin D1. In 
fact, in the liverspecific STAT3-KO model mice, mitotic activity of hepatocytes after PH is 
reduced significantly (43). 
The PIK/PDK1/Akt signaling pathways are activated by receptor tyrosine kinases or 
receptors coupled with G proteins by IL-6, TGF-HGF, EGF, TGF-and others (39). 
An important downstream molecule of Akt for cell growth is mTOR. The activation of this 
pathway coexists with STAT-3 signaling. In STAT-3-KO mice no significant differences 
were observed macroscopically in liver regeneration in comparison to control animals, 
reaching the liver of these mice after PH an equal size. This observation may be explained 
considering the increase in size of the hepatocytes. Increase in cell size corresponds to 
marked phosphorylation of Akt and its downstream molecules p70 S6K, mTOR and 
GSK3beta (33). 
The third phase in liver regeneration is the termination step. A stop signal is necessary to 
avoid an inappropriate liver functional size but the molecular pathways involved in this 
phenomenon are not yet clear. A key role is exerted by the cytokine TGF-, secreted by 
hepatocytes and platelets, that inhibits DNA synthesis (50). In fact, within 2-6 hours after 
PH, the insulin growth factor (IGF) binding protein-1 (IGFBP-1) is produced to counteract 
its inhibitor effects. 
 
 
 
 
 
 
 
 19 
 
 
 
 
Figure 3. Schematic representation of the priming events leading to liver reconstruction after partial hepatectomy. 
Hepatocytes priming is induced by the cumulative action of TNFa and IL6 secreted by activated Kupffer cells, HGF secreted by activated stellate 
cells, and HGF and Wnt2 secreted by LSECs.  
Figure by Moniaux N. et al., 2011. 
 
 
 
 
1.4 Liver sinusoidal endothelial cells (LSECs) 
 20 
 
 
THE LIVER SINUSOIDAL ENDOTHELIAL CELLS (LSECs) are a morphologically and 
functionally unique sub-population of liver endothelial cells that form the lining of the 
hepatic sinusoids. These cells comprise the vast majority of endothelial cells within the 
liver, but differ dramatically from endothelia of other organs. They have a unique phenotype 
that is well integrated into the special needs of the liver. They possess fenestration and are 
lack of membrane basal.    
Fenestrations are approximately 50–150 nm in diameter and most are aggregated into 
groups of 10–100, so-called liver sieve plates (19). The diameter and number of 
fenestrations are altered by various liver diseases, diabetes mellitus and old age and are 
influenced by cytokines and hormones . Alteration in the size and number of fenestrations 
influences the hepatic trafficking of lipoproteins, clearance of pharmaceutical agents , liver 
regeneration and interactions between lymphocytes and hepatocytes (20).This freer access 
to blood permits greater oxygenation of hepatocytes and more efficient clearance of drugs 
and perhaps also of chylomicron remnants. Cross-talk between SEC and hepatocytes may 
also be critical for recovery of hepatocytes from toxic injury. Capillarization is a change in 
the phenotype of the SEC to avascular phenotype with loss of fenestration and formation of 
an organized basement membrane. Capillarization is a dedifferentiation process that can be 
reproduced with experimental interventions in vivo  and in vitro in SEC (22) but that also 
occurs in vitro over time with SEC in culture. Capillarization precedes the onset of alcoholic 
liver disease in humans and mice and has been seen in various rat models of fibrosis and 
cirrhosis (22). Aging is accompanied by a change in SEC phenotype with loss of 
fenestration but with less extensive changes in the basement membrane. Given the limited 
changes in the basement membrane, this change in SEC phenotype has been referred to as 
pseudocapillarization (21). Determinants of endothelial cell phenotype include heterotypic 
contact with pericytes or smooth muscle cells, paracrine effects of epithelial cells, shear 
stress, and the underlying substratum. Little is known about the determinants of the normal 
SEC phenotype. Proximity to liver tissue can induce the SEC phenotype (31), but the 
pathways that regulate this have not been established. One of the limitations to performing 
studies of SEC phenotype has been the lack of a practical marker for the normal, 
differentiated phenotype. While the above concepts represent significant advances in our 
understanding of the physiology and pathology of the unique endothelia within in liver, 
many aspects of the biology of these cells remain poorly understood, due in part to the 
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relative paucity of appropriate in vitro models. The development of several methods to 
isolate liver endothelial cells from experimental animals, while a significant and critically 
important advancement, still leaves certain limitations in term of rapid, high-troughtput, and 
reproducible hypothesis testing. This is because primary cells are generally difficult and 
time–consuming to isolate, limited in number, invariably contain impurities with other cell 
types, and may lack the features of pathologic vasculature. Further, the isolation procedures 
themselves may affect cell viability and phenotypic homogeneity(46).  
A defining feature of sinusoidal endothelial cells is the presence and type of adhesion 
molecules. CD31, or platelet endothelial cell adhesion molecule, is an adhesion molecule 
that is present on the cell-cell junctions of most endothelial cells and that facilitates 
leukocyte transmigration. Immunohistochemical studies have demonstrated that 
differentiated SEC in situ do not express CD31 but that CD31 becomes detectable on SEC 
in cirrhosis and in focal nodular hyperplasia (19), presumably in areas with capillarization. 
In contrast, more recent studies (19) have detected CD31 on normal SEC in situ. A recent 
paper was able to culture human SEC over time and maintain some degree of fenestration 
and an absence of basement membrane. In these fenestrated SEC, CD31 could only be 
demonstrated by flow cytometry after permeabilization, suggesting an intracellular 
localization (35). If this is indeed the case, then the discrepancy in previous studies as to 
whether CD31 is expressed in normal SEC might be related to differences in 
permeabilization techniques. SEC are small, flat cells, and the localization of CD31 would 
not be appreciated on light microscopy of SEC in situ. More studies used also other markers 
as sinusoidal endothelial markers, such as: CD105 (endoglin), CD144 (VE-Cadherin), KDR 
(VEGF receptor 2), vWF (von-Willembrand-factor), MECA 32 (pan endothelial cell 
antigen), Lyve 1 (receptor scavenger 1) and caveolin. 
The peculiarity of LSEC is presence of fenestrations, but no markers have been reported that 
specifically label fenestrations and the mechanisms for the regulation of their formation and 
size remain unclear. The most consistent findings of biological relevance are that 
fenestrations are increased by actin-disrupting agents and by the angiogenic cytokine, 
vascular endothelial growth factor (VEGF) (65). The mechanisms that regulate fenestrations 
need to be clarified in order to develop strategies to improve lipoprotein metabolism in old 
age and liver disease (46) and to enhance liver regeneration. Fenestrations are smaller than 
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the limit of resolution of light microscopy and most studies have relied upon electron 
microscopy with inherent problems related to fixation of tissue. Recently three dimensional 
structured illumination fluorescence light microscopy (3D-SIM) was applied to LSECs and 
their fenestrations (35). The morphology of the fenestrations and sieve plates was very 
effectively resolved by 3D-SIM, providing for the first time a detailed three-dimensional 
map of their structure. 
 
 
1.4.1 Sinusoidal endothelial cells and regeneration 
 
The precise molecular and cellular mechanism driving the regenerative capacity of the liver 
are still not fully comprehended. Liver regeneration after partial hepatectomy is 
characterized by a compensatory hyperplastic response of the mature differentiated remnant 
liver cells, which lasts until the original liver mass is restored. 
The groundbreaking work of Ding et al.(23) recently published reveals that the liver 
sinusoidal endothelial cells (LSECs), which harbour a specific VEGFR2+ VEGFR3+ CD34- 
VE-cadherin+ factor VIII+ CD45- phenotype play a crucial role in the triggering of 
hepatocyte proliferation. These authors report a biphasic proliferative wave of hepatocytes 
during the first 3 days after partial hepatectomy, and then of LSEC from 4 day to day 8. 
Using knockout mice models, they showed that partial hepatectomy induced VEGFR2 
activation at cell surface of LSECs, initiating Id1 up-regulation and secretion of HGF and 
Wnt2 angiocrine factors. The production of HGF and Wnt2, as well as the direct contact 
between LSECs and hepatocytes were clearly necessary conditions for the first wave of 
hepatocytes proliferation to occur. Subsequently, the VEGFR2-Id1 pathway promoted 
neoangiogenesis to ensure blood supply of the growing liver. Ding et al. raise the unsolved 
question of how LSECs sense partial hepatectomy and suggest that they respond to some 
imbalance of the inhibitory factors, which maintain the mass of the liver. These conclusions 
may be compared to those of recent work by Ninomiya et al.(49) showing that a decrease in 
liver regenerative speed caused by ERK/MEK inhibitors reduced the small-for-size 
syndrome in 70% or 90% partial hepatectomy in rats. The latter authors conclude that the 
abrupt regenerative response of hepatocytes to resection stifles the sinusoids, resulting in 
hypoxia of the hepatocytes and liver disfuction. A syncronized replication of hepatocytes 
and SECs is thus a crucial requirement for proper liver regeneration (Figure 5)(45). 
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In conclusion, Ding et al. have a cast light on a several crucial aspects of the regulation of 
the initial steps of liver regeneration and DNA synthesis in hepatocytes. Using VEGFR2 and 
Id1 knockout mice enabled them to show that HGF production by non-endothelial cells, 
such as stellate cells, was not a sufficient condition for hepatocytes proliferation. Secretion 
of HGF and Wnt2 by LSECs was also necessary. The identification and characterization of 
the soluble factors that promote activation of LSECs and HGF/Wnt2 secretion will provide 
valuable tools of future therapeutic developments. In agreement, the close contact between 
LSECs and hepatocytes was necessary for triggering liver regeneration. Hence, recent 
research findings point toward the importance of SECs in the hepatocyte response to partial 
hepatectomy and should impact the design of future regenerative medicine based on 
hepatocyte or stem cell transplantation for the treatment of end-stage liver disease.  
 
 
 
 
 
 
 
 
Figure 3. Schematic representation of the role of 
SECs during the priming events leading to liver 
reconstruction after partial hepatectomy. 
Hepatocytes priming is induced by the cumulative 
action of TNF and IL6 secreted by activated Kupffer 
cells, HGF secreted by activated stellate cells, and 
HGF and Wnt2 secreted by LSECs. Hepatocytes 
induces SECs proliferations  at 7sh after PH. Activated 
SECs produce angiogenic factors and were induced by 
avasculated parenchymal cells to invade the liver 
mass. After 96-120h, SECs forms sinusoids and 
complet the angiogenic processes  
Figure by Ross M.A. et al., 2001 
 
 
 
 
 
 
1.5 Hepatic Stellate cells (HCSs) 
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HSC, also called perisinusoidal cells, Ito cells or fat-storing cells, reside in the space of 
Disse – the perisinusoidal space between the basolateral surface of hepatocytes and the anti-
luminal side of sinusoidal endothelial cells (4). Under normal physiological conditions in 
the adult liver, HSC are morphologically characterized by extensive dendrite-like extensions 
that wrap around the sinusoids, essentially “embracing” the endothelial cells (29). This close 
contact between HSC and their neighboring cell types facilitates intercellular 
communication by means of soluble mediators and cytokines. HSC store vitamin A, control 
turnover and production of ECM, and are involved in regulation of sinusoid contractility. 
HSC can be identified by the expression of desmin, a typical intermediate filament protein 
within contractile cells. Mature HSC produce both network and fibrillar collagens (large 
amounts of type I collagen and lower levels of type III, IV and V collagen), large amounts 
of elastin and both heparan sulfate proteoglycans (HS-PG) and chondroitin sulfate 
proteoglycans (CS-PG). HSC also produce important cytokines and growth factors for 
intercellular communication in normal and injured liver. These include hepatocyte growth 
factor (HGF), transforming growth factor-α (TGF-α) and epidermal growth factor (EGF), 
three potent growth factors for hepatocyte proliferation during liver regeneration (4;29). 
TGF-α and EGF also stimulate mitosis in stellate cells themselves, creating an autocrine 
loop for cellular activation. Insulin-like growth factor (IGF-I and II) and platelet-derived 
growth factor (PDGF), among the most potent HSC mitogens, are also secreted by stellate 
cells. 
Collectively, these factors allow HSC to influence their own gene expression and phenotype 
as well as that of other cells of the liver. Following liver injury, HSC become activated to a 
myofibroblastic (MF) phenotype characterized by a loss of vitamin A and expression of α-
smooth muscle actin (α-SMA) (29). In this activated state, MF-HSC produce growth factors 
and cytokines, such as transforming growth factor β (TGF-β), which play a key role in the 
regulation of hepatocyte growth and the development of inflammatory fibrotic response of 
the liver (42). Connective tissue growth factor (CTGF) is also expressed by HSC and 
promotes fibrogenesis. HSC participate significantly in the inflammatory response of the 
liver through secretion of cytokines, such as macrophage colony-stimulating factor (M-
CSF), which regulates macrophage accumulation and growth, interleukins-8 and -6 (IL-8, 
IL-6), monocyte chemotactic peptide (MCP)-1, CCL21, RANTES, CCR5, and the anti-
inflammatory IL-10. Activated HSC express toll-like receptors (TLRs) allowing them to 
recognize bacterial endotoxin lipopolysaccharide (LPS) and function as APC. HSC also 
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amplify the inflammatory response by inducing infiltration of leukocytes. HSC are involved 
in the onset and progression of cirrhosis, which is typically associated with highly activated 
cells leading to a fibrotic response, a progressive increase in deposition of ECM proteins 
and scar tissue formation throughout the liver. A major contributing factor includes the 
production of the potent vasoconstrictor ET-1. ET-1 has a prominent contractile effect on 
HSC and MF-HSC, which may contribute to portal hypertension in the cirrhotic liver. 
Activated HSC also produce elevated levels of extracellular matrix proteins (e.g. collagen 
types I, III, IV, V) and various basal adhesion molecules (fibronectin, and laminin α1 and γ1 
chains) that contribute to scar tissue formation throughout the liver (42). 
 
 
1.5.1 Hepatic stellate cells (HSC)  and regeneration 
 
Hepatic stellate cells (HSCs) can be found within the progenitor cell niche in normal and 
regenerating liver, which is situated near the Canals of Hering (63). The functional 
importance of these stellate cells is supported by evidence that mouse fetal liver derived-
Thy+ cells, which express classical features of hepatic stellate cells (a-SMA, desmin and 
vimentin), promote maturation of hepatic progenitors through cell-cell contact in culture. 
Similarly, another stellate cell-derived morphogen, pleiotrophin, is also secreted by stellate 
cells and may contribute to hepatocyte regeneration. Stellate cells may also be vital to the 
development of intrahepatic bile ducts during development. 
In addition to their emerging role in hepatic development, there is growing evidence that 
stellate cells are also vital to the hepatic regenerative response in adult liver, but further 
investigation is urgently needed. An important study has identified neurotrophin signaling as 
a paracrine pathway in stellate cells that contributes to hepatocellular growth after injury, in 
part trough stimulation of HGF secretion by stellate cells. In a similarly approach, mice 
heterozygous for the FPXf1 fork head transcription factors display defective stellate cells 
activation after CCl4 administration, as assessed by a-SMA expression. At the same time, 
these animals have increased liver cell injury and apoptosis, but reduced fibrosis. Also, the 
animals have defective epithelium regeneration, although it is difficult to tease out potential 
mechanism based on these data alone (29).  
The role of HSCs in hepatic regeneration would be ideally addressed if methods are 
developed to determine the impact of ablating or inactivating these cells on regeneration of 
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normal liver following partial hepatectomy. A genetic model of cell-specific deletion has 
been quite informative in understanding the role of hepatic macrophages in liver injury and 
repair, for example. 
A number of potential hepatocytes mytogens are secreted by stellate cells, including HGF, 
epidermal growth factors, epimorphism, and pleiotrophin. As yet, however, their relative 
contribution and modes of regulation during hepatic regeneration have not been clarified. 
Even more interesting, a subset of hepatic stellate cells express CD133 which have a 
pleuripotent potential in developing or adult liver. This very intriguing finding merits further 
exploration, as two recent studies have identified CD133 as a marker of stemlike cells in 
several tissue, including colon cancer.  
HSCs respond to a proliferative stimulus of partial hepatectomy similarly to other liver cells, 
by a semi-synchronous wave of proliferation that comes to a halt when the liver has 
achieved its original mass. The factors initiating and terminating this proliferative surge are 
emerging.  
Rat HSCs produce IL-6 and have receptors for IL-6, suggesting an autocrine role for IL-6 in 
HSC proliferation. Stimulation of rat HSCs with human recombinant IL-6 augmented HSC 
proliferation. In contrast, transgenic mice overexpressing the IL-6 receptor showed 
inhibition of hepatocyte proliferation, correlated with an increase in p21, a cell cycle 
inhibitor protein, suggesting that hyperstimulation with IL-6 can also inhibit liver 
regeneration, at least in this transgenic model. 
Today, is needed to understand the role of HSCs during liver regeneration or the possible 
role of Stellate Progenitor Cells. this is a progenitor cells not yet identified and for which 
community scientific try an answer. 
 
 
1.6 Liver progenitor cells  
 
HPC are bi-potential stem cells residing in human and animal livers that are able to 
differentiate towards the hepatocytic and the cholangiocytic lineages. The HPC reside in a 
compartment contained within the canals of Hering. These canals represent the smallest and 
most peripheral branches of the biliary tree connecting the bile canalicular system with the 
interlobular ducts. In normal adult liver, HPC are small, quiescent cells with elongated or 
vesicular nuclei, small nucleoli and scant cytoplasm. Under normal circumstances they have 
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a relatively low proliferation rate and represent a reserve compartment that is activated only 
when the mature epithelial cells of the liver are continuously damaged or inhibited in their 
replication, or in cases of severe cell loss. Under these conditions, resident HPC are 
activated and expand from the periportal to the pericentral zone giving rise to mature 
hepatocytes and/or cholangiocytes). In rat liver, the HPC are activated and induced to 
proliferate by various hepatocarcinogens and other noxious stimuli whereupon their nuclei 
acquire an oval shape, thus the name ‘oval cell’ in the early literature 
 The HPC niche is defined as the cellular and extracellular microenvironment which 
supports the stem cell populations and contributes to sustain self-renewal and is composed 
of numerous cells, such as LSEC, HC, cholangiocytes, KC, pit cells and other inflammatory 
cells (1). All of these cells in combination with numerous hormones and growth factors 
interact and cross-talk with progenitor cells influencing their proliferative and differentiative 
processes. The unique microenvironment and interaction with the specific cell types is 
thought to be a key mechanism in regulating the maintenance of self-renewal and 
maturation capacities by stem cells. Nevertheless, a number of different types of signaling 
and adhesion molecules within the niche influence stem cell quiescence, self-renewal and 
cell fate decisions. In fact, this niche environment has been associated with regulating key 
stem cell functions, such as maintaining stem cell quiescence and providing proliferation- or 
maturation-inducing signals when numerous progenitor cells are required to generate mature 
cell lineages. 
 
 
1.6.1 Liver progenitor cells and regeneration 
 
When liver parenchyma damage is particularly serious and hepatocytes are no longer able to 
proliferate, liver regeneration can occur through the intervention of bipotent progenitor cells 
that can proliferate and differentiate into hepatocytes and bile duct cells.  
It was 1950 when Wilson and Leduc, studying the regeneration of rat liver after severe 
nutritional damage, observed for the first time these particular cells, located within or 
immediately adjacent to the Canal of Hering, and their differentiation into two histological 
types of liver epithelial cells (77). In 1956 Faber called these cells, which are found in the 
liver of mice treated with carcinogens (25), "oval cells" for their morphology. The first 
characterization of oval cells has shown the simultaneous expression of bile ducts (CK-7, 
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CK-19 and OV-6) and hepatocytes (alpha-fetoprotein and albumin) markers (41). 
Subsequent studies have shown the activation, during oval cell compartment proliferation, 
of stem cell genes such as c-kit (30), CD34 (55) and LIF (56) . 
Stable lines of oval cells, useful for in vitro and in vivo studies of differentiation and of liver 
colonization, were obtained from normal rat liver F-334, or from rats fed with DL-ethionine 
(63) or treated with ally alcohol (79). In addition, these precursors were stabilized starting 
from liver explants of animal models of Wilson disease (78) of transgenic mice expressing 
Ras of p53 knockout mice fed with choline-free diet and finally of human liver (24). 
The oval cell is currently the best characterized liver progenitor cell although several studies 
have demonstrated the presence of precursors/stem cells either residing in the liver or 
coming from blood. Regardless of the species in which were observed and the name that 
was given to them, the progenitor cells of the liver have common characteristics: 
 they are very few and hardly recognizable in the healthy liver, but clearly evident as 
a result of chronic liver injury near the terminal trait of biliary duct; 
 they express cholangiocyte and hepatocyte markers; 
 they are basophilic, with a high ratio of nucleus/cytoplasm and are smaller than 
mature hepatocytes (10 μM in diameter compared to 50 of hepatocytes); 
 they are immature and have a great proliferative capacity. 
Further than oval cells, other bipotential precursor cells able to differentiate and colonize 
diseased liver in animal models have been isolated from rodent and human livers, allowing 
the study of molecular mechanisms triggering their differentiation.  
The development of an oval cell reaction in response to hepatocyte replicative senescence 
has also been demonstrated in a transgenic mouse model of fatty liver and DNA damage. In 
both humans and mice, the extent of this reaction is dependent on the severity of the 
damage. This so-called ‘oval cell’ or ‘ductular reaction’ amplifies a cholangiocyte derived 
(biliary) population before these cells differentiate into either hepatocytes or cholangiocytes. 
The AAF/PH model in the rat will be used to illustrate both the cellular biology and growth 
factor/receptor systems involved in stem cell-energized liver regeneration. In this 
experimental system, a rapid and extensive proliferation of oval cells takes place after PH, 
first in the periportal area; later, these cells expand into the liver acinus and differentiate into 
small basophilic hepatocytes. (69).The powerful activation of the stem cell compartment 
seen in the AAF/PH model is a consequence of a close to complete mitoinhibitory effect of 
AAF on the adult rat hepatocytes that prevents the regeneration from the remaining liver 
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tissue. It has been established that proliferation of desmin-positive Ito cells is closely 
associated with the early stages of oval cell proliferation in the AAF/PH model. Early 
population of oval cells can be identified by the use of the monoclonal antibody OV-6 and 
distinguished from proliferating desmin-positive Ito cells. Results from a detailed time 
course study of activation of hepatic stem cells in the AAF/PH model, utilizing a 
combination of immunohistochemistry with OV-6 and desmin antibodies and 
autoradiography after [3H]thymidine administration shortly after the PH, indicate that the 
earliest population of proliferating OV-6 positive cells is located in the small bile ductules 
(69). In addition, these early populations of OV-6-positive cells express albumin and a-
fetoprotein (AFP). These data clearly show that the majority of thymidine-labeled, OV-6-
positive cells first observed after PH in the AAF/PH model reside in the bile ductules. 
Moreover, at the time when few of the OV-6-positive cells in the large bile ducts become 
labelled with thymidine, the ductular-derived OV-6-positive and thymidine labeled “oval” 
cells expressing both albumin and AFP have already started to infiltrate into the liver acinus 
(69). It therefore seems likely that the major source of oval cells, at least in the AAF/PH 
model, is derived from the lining cells of the biliary ductules and that these cells constitute 
the dormant/facultative hepatic stem cell compartment. 
During normal hepatic regeneration as well as during renewal from the stem cell 
compartment, several growth factors appear to affect the proliferation and differentiation 
of hepatic cells. The question therefore arises as to whether the same growth factors known 
to be involved in normal hepatic regeneration are also involved in regeneration from the 
stem cell compartment. 
There are three “primary” growth factors associated with normal liver regeneration: 
transforming growth factor alpha (TGF-), hepatocyte growth factor (HGF), and 
acidic fibroblast growth factor (aFGF). Each of these growth factors is also capable of 
inducing replication of primary hepatocytes in vitro . In addition, transforming growth 
factor-beta 1 (TGF-1) is also expressed during hepatic regeneration, and it has been 
proposed that TGF-1 may provide at least part of the negative growth signals controlling 
liver size after the compensatory hyperplasia that occurs after loss of liver mass (69). The 
first cells entering DNA synthesis after PH in the AAF/PH model are the OV-6 and desmin-
positive bile duetular and Ito cells, respectively, in the periportal area. Coincident with the 
appearance of these cells, an increase in the expression of TGF-, HGF, and TGF-1 is 
observed, whereas increased expression of aFGF is first seen 24 h later. All the growth 
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factors are then expressed at high levels throughout the period of expansion and 
differentiation of the oval cells and return to levels seen in normal liver at the end of the 
regeneration process. The cellular distribution of the growth factor transcripts differs: TGF-
 and aFGF transcripts are found both in Ito cells and oval cells, whereas the HGF 
transcripts are only found in Ito cells. The TGF-1 transcripts are located mainly in Ito 
cells, but the early population of oval cells also contain the TGF-1 transcripts. The cellular 
distribution of the transcripts for all the receptors corresponding to the growth factors has 
revealed that all are located on oval cells. These data suggest that the same primary growth 
factors involved in liver regeneration from existing differentiated parenchyma are also 
involved in regeneration from the stem cell compartment. 
Another mechanism is the ligand/receptor system, the stem cell factor (SCF)/c-kit system, 
which may be uniquely involved in the earliest stages of hepatic stem cell activation, was 
discovered. In the AAF/PH model, the expression of both SCF and c-kit is seen before the 
expression of AFP, and the levels of both the SCF and the c-kit transcripts decline before 
those of TGF-, aFGF, HGF, and TGF-1. It has also been shown that in contrast to TGF-
a, HGF, aFGF, and TGF-1, the SCF/c-kit system is only slightly and transiently activated 
in regeneration after PH in normal liver. The SCF/c-kit signal transduction system is 
believed to play a fundamental role in the survival, proliferation, and migration of stem cells 
in hematopoiesis, melanogenesis, and gametogenesis. It appears that in all cases, SCF and c-
kit are involved in the early stages of stem cell activation. Whether the SCF/c-kit system in 
the early hepatic stem cell population interacts with other hepatic growth factors so as to 
influence the frequency of lineage commitment of progenitor cells is not known at present. 
However, the hepatic expression pattern and cellular location of the SCF/c-kit system 
indicate that this signal transduction system is required only during the early activation and 
transitional phase of the oval cell differentiation. Once the oval cells have differentiated into 
the small basophilic hepatocytes, the expression of both SCF and c-kit is abolished. After 
the hepatocyte population is reduced by, for example, PH, the residual hepatocytes 
proliferate promptly, continue to cycle until the deficit is repaired, and continue 
to function while proliferating. Under these conditions, no apparent contribution to the 
regeneration process is provided by the stem cell compartment. Activation of oval cell 
proliferation and differentiation by injury, which is more severe and/or qualitatively 
different from the simple loss that triggers only hepatocyte proliferation, results in transient 
 31 
 
reestablishment of a hepatocytic lineage that has all the characteristics of a potential or 
facultative stem cell system.  
Cells in the normally quiescent stem cell compartment are activated to produce poorly 
differentiated oval cell progeny. Oval cells proliferate extensively to yield a large population 
of cells that migrate throughout the parenchyma, some of which differentiate as they 
migrate. Hepatic progeny of oval cells merge into the functional compartment of mature 
hepatocytes and help restore the parenchyma. Similar to the generation of new hepatocytes 
after simple loss, the production of hepatocytes via the stem cell (oval cell) mechanism is 
also episodic and transient. These two distinct mechanisms of hepatocyte formation are both 
subjected to several points of stringent control. Controls are required to regulate the 
reinitiation of hepatocyte formation from the normally quiescent hepatocytes, as well as to 
regulate the activation of potential stem cells that energizes cell flow through the entire 
lineage. Although the controls may differ between the two mechanisms of hepatocyte 
formation, it is probable that both pathways are simultaneously activated after loss of liver 
mass, including that after simple PH. 
One of the earliest phenotypic indications of liver stem cell activation is the expression of 
AFP. A transient expression of AFP is also seen after simple PH and similar to that seen in 
stem cell activation in the AAF/PH model, the AFP transcripts are located in the bile 
ductules. Expression of both SCF and c-kit is also transiently elevated after standard PH. 
However, there is no evidence indicating that the stem cell-derived hepatocytes significantly 
contribute to regeneration of liver mass after simple PH. These observations suggest that the 
activation, and in particular, the expansion of liver stem cells, are stringently controlled 
during hepatocyte-driven liver regeneration. 
In a healthy liver, the reparative renewal of the hepatocyte and biliary epithelial cell 
populations is accomplished in most instances by proliferation of residual differentiated 
cells of each types , resulting in only a transient activation of the stem cells. However, under 
conditions in which the hepatocytes are unable to respond to the regenerative stimuli and/or 
are functionally compromised, a sustained activation of the stem cells and their progeny 
ensues, generating the differentiated cell lineages needed for the liver regeneration. An 
essential requirement for the stem cell-driven liver regeneration is a sustained expression of 
a set of growth factors, including those known to be involved in liver regeneration after 
simple PH. 
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1.7 Liver Tissue engineering 
 
Tissue engineering (TE) is a multidisciplinary science aimed at developing “biological 
substitutes to restore maintain or augment tissue function”, and holds premise for the 
development of innovative alternatives to hepatic disease. The ideal biological liver 
substitute should perform most or all of the liver-specific detoxification, synthetic and 
biotrasformation functions. As most of these functions are still unknown, mature liver cells 
(e.g. primary or immortalized) or cells that may differentiate into hepatocytes (e.g. stem or 
progenitor oval cells) have been used in these substitutes to perform liver-specific functions. 
Typically, liver constructs are engineering in vitro by culturing liver (or like-liver) cells 
in/on synthetic scaffolds which provide the template for cell adhesion, re-arrangement, 
proliferation and development (6). 
The development of constructs with metabolic functions equivalent to those of the liver 
poses technical challenges well beyond that of developing new culture techniques (e.g. 2D 
monolayer vs.3D culture) for the complexity of liver cell physical-chemical requirements 
and the scale of the constructs. In fact, the liver is a highly structured organ with many 
distinct cell sub-population. Liver cells are spatially organized to optimize communication 
and transport. Cells communicate directly through cellular and gap junctions, and via 
chemical signals dissolved and blood-borne or present in the macromolecules forming the 
ECM that surrounds them. The signals that cells exchange promote differentiation, 
proliferation and functions. Furthermore, metabolic (e.g. carbohydrate metabolism) and 
detoxificant (e.g. CYP450 enzymes) activities of the hepatocytes change spatially along the 
length of the sinusoid, apparently regulated by gradients of oxygen, hormones and ECM 
composition, a phenomenon termed “liver zonation”. Information on the structure-function 
relationship for normal and pathological liver tissue is still lacking. Fostering the same 
cellular relationship existing in the normal liver also in the TE liver construct is considered 
fundamental for cells to function as in the natural liver (11). 
Over the years, research has mainly focused on the procurement of large amounts of suitable 
liver cells and the development of in vitro culture techniques.  
Cultured primary and immortalized hepatocytes have been used for decades to address a 
wide variety of pharmacological and toxicological research topic (6).One shortcoming of 
conventional 2-D monocultures of hepatocytes utilized traditionally for compound testing is 
the partial or complete loss of viability and phenotype over time in culture. When reflecting 
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on the various factors that dictate the expression of normal hepatic phenotype in vivo, it is 
easy to understand that much of the conditional loss of structure and function in vitro is due 
to the loss of physiological context under conventional culture conditions. In many respects, 
the loss of normal cell structure and function in vitro is in reality an adaptation to the 
preparation and cultivation process that causes a shift in the gene program expressed in the 
cells as requisite contextual signals are lost.  
Hepatotoxicity in vivo is often dependent on specific anatomical, morphological and 
phenotypic properties of the individual cell types that comprise the liver microenvironments 
in vivo.  
The three-dimensional relationships of the unique cell types within the microenvironments 
of the liver (e.g. periportal versus pericentral), the regional hemodynamic flow patterns, and 
other physiological factors, such as oxygen tension and cytokine profiles, all play important 
roles in determining the toxicokinetics and toxicity of particular compounds(45). 
Current cell-based models that are routinely utilized to perform toxicity testing in vitro are 
generally simple culture platforms (typically standard microtiter plate formats) employed 
under static, nonphysiologic conditions. Due to their simplicity, these static, monoculture 
model systems often represent suboptimal models for drug and chemical safety testing that 
are not able to mimic or predict more complex MOA. One of the biggest challenges to the 
development of more organotypic in vitro models of the liver is the integration of the 
architectural and cellular complexities of the liver, while incorporating the important 
elements of the localized hemodynamics of the regional microenvironments (6). 
 
Increasing research effort is being devoted to the development of biomaterials for liver cells 
scaffolding at whose surface topological, morphological and biochemical signals are present 
to attract cells and make them adhere and rearrange their cytoskeleton, and to the 
characterization of the dissolved biochemical and physical signals that control cell 
differentiation, proliferation and apoptosis. 
Worldwide, there is a growing interest for such innovative cell-based therapies as an 
alternative for orthotopic liver transplantation. If numerous clinical reports have established 
the efficacy of cell infusion therapies for the correction of inborn metabolism disorders, 
their clinical potential for the treatment of acute liver failure remain uncertain, mostly 
because engraftment efficiency can be poor in a situation without proper liver architecture. 
In the light of the current results, improvement of these therapies may require to co-infusion 
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of hepatocytes-stem cells with SECs or the use of a mimetic scaffold. In addition, Uygun et 
al. demonstrated that hepatocytes engraftment into a decellularized liver scaffold allowing a 
perfect lining of hepatocytes along fully functional SECs, was much more efficient than 
direct transplantation within the liver (45). 
Until now, exist different approach to construct a bioartifical liver. 
Three dimensional (3D) implantable constructs are made of porous biomaterials that 
degrade and resorb at controlled rates to permit their replacement with the extracellular 
matrix (ECM) produced by the cells, and cell colonization of the construct. Once implanted 
in vivo, the graft has to fully integrate into the body of the host. Two-dimensional (2D) or 
3D non-implantable constructs may be used ex vivo  for the EC support of ALF patients till 
a tissue compatible organ is available on the patient’s own liver heals(6). 
 
 
1.8 Bioreactor devices 
 
A bioreactor may possibly be defined as a volume (or vessels) in which one or more 
biochemical or biological processes take place. Indeed, bioreactors are extensively used at 
any step of the assembly of a TE liver construct. In fact, primary cells enzymatically 
isolated from autogenous or allogenic liver tissue (or the whole organ) are often cultured in 
Petri dishes or T-flasks prior to their seeding in the scaffold to let them recover from 
isolation and purification stress. 
Immortalized and primary progenitor or stem liver cells are generally expanded in Petri 
dishes or T-flasks, often under conditions facilitating differentiation to mature hepatocytes 
of the first two cell types, of inhibiting differentiation to maximize proliferation of the third 
cell types. 
Liver cells (often of different types) are harvested and seeded in/on synthetic scaffolds in 
bioreactors under conditions that should facilitate cell attachment to the scaffold surface and 
penetration into its pores. The cell-seeded scaffolds are then cultured in bioreactors under 
tightly controlled and closely monitored environmental conditions to provide cells with 
biochemical and physical cues that should promote cell reorganization into liver-like 
aggregates and differentiation to make the construct functionally equivalent to liver 
tissue(6). 
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The first step in the development of constructs for liver replacement is to seed a large mass 
of liver cells uniformly on, or throughout, a scaffold. Then, the adherent cells have to be 
provided with adequate amounts of oxygen and nutrients to survive and proliferate, and 
adequate biochemical/physical signals to re-organize and differentiate to yield cellular 
structures and metabolic zonation resembling that the liver. Attaining adequate cell seeding, 
nutrient and oxygen supply to cells, and the control of biochemical signals gradients and 
concentrations in large scaffolds is not easy and depends on the bioreactor configuration and 
operation, on how mass is transported outside and inside the scaffold, and on cell 
metabolism. Bioreactors used for extracorporeal liver support have also to be connected to 
the patient so as to guarantee the unhindered transport of soluble species from the patient’s 
circulation to the cells in the bioreactor and vice versa. 
Cell seeding is thought to play a crucial role in the development of in vitro engennered 
tissue. Seeding cells at high initial density may favour tissue formation. High seeding 
efficiency would also limit the amount of organ tissue from which primary cells are isolated 
and cell expansion. Uniform initial cell distribution on 2D or throughout 3D scaffold has 
been related to the uniformity of engineered cartilage and bone tissue. Uneven cell 
distribution in the scaffold might lead to spatial variations in nutrients, oxygen and 
metabolic concentrations that would condition the survival and metabolism of cells at 
different positions in the scaffold. Seeding cells efficiently and uniformly on/in a scaffold is 
challenging, in particular throughout 3D porous scaffolds. In fact, closed or tight pores 
inside the scaffold may limit cell access and the seeding efficiency and distribution. Cell 
distribution in accessible pores depends on the balance between the rate at which cells are 
physically transported from the medium bulk to the outer scaffold surface (i.e. external 
transport) and from there towards its innermost pores (internal transport), and the rate at 
which cell bind to the biomaterial pore surface or to other cells in the feed suspension and 
form clusters (57). In particular, the resistance to external transport and cell uniformity in 
the feed suspension may be varied by changing the mixing intensity in the bioreactor where 
seeding takes place. Resistance to internal transport depends on the cell-to- pore size ratio 
but also on the transport mechanism within the scaffold. 
Another limits on the bioreactor’s perform “nutrient and metabolite transport”. Growing 
liver tissue in vitro for liver replacement or support is more difficult than other tissues. In 
fact, cells have to be cultured at the high density typical of the natural liver, much higher 
than in many other tissues. Liver cells have also important nutrient requirements and are 
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sensitive to waste metabolites. In vivo, the liver is efficiently provided with soluble nutrients 
by a high blood flow that reaches the innermost cells in the organ by means of a fine 
network of capillaries (i.e. the sinusoids). This keeps the diffusion distance between cells 
and the blood small (within a few hundreds micron). Providing ad analogous system to 
supply basic substrates (oxygen, glucose and amino acids) to or clear waste metabolites 
(CO2, ammonia, urea, lactate) from liver cells in large 3D constructs is a formidable 
challenge, and a pre-requisite to promote cell growth, differentiation and a long-term 
survival (11). In fact, nutrients are continuously consumed (and products formed) by the 
cells while they are transported from the source into the cell mass (or from the cells to the 
skin). This causes the concentration of soluble nutrients in the cell mass to be generally less 
than that near their source, and the formation of concentration gradients across the cell 
construct. 
 
 
1.9 Cell sourcing  
 
In response to the increasing incidence of liver disease and the relative shortage of donor 
organs, many investigators have developed cellular therapies using isolated hepatocytes. 
Such approaches must consider both the source of hepatocytes and crucial stabilization of 
liver-specific function. Cell-based therapies that are reviewed can be generally categorized 
as extracorporeal devices, cell transplantation, and tissue-engineered constructs. 
The choice of cell type in any cellular therapy is of paramount importance. Unfortunately, 
the full complement of cellular functions required to replace the liver and positively affect 
clinical outcomes has not been determined. For example, the mediators of hepatic 
encephalopathy resulting from liver decompensation are not fully understood although many 
theories, such as accumulation of ammonia,17 benzodiazapine,18 or gut-derived 
neurotransmitters,19 have been proposed. Hence, functionality of cellular devices is 
determined by “surrogate” markers of each class of liver-specific functions including 
synthetic functions, metabolic functions, detoxification (phase I and II pathways), and 
biliary excretion. The implicit assumption is that hepatocytes capable of a wide array of 
known functions will also express those unmeasured (or unknown) functions that are central 
to their metabolic role. Tissue-engineering applications may now consider sources other 
than primary cells as new cell lines are developed and stem cell lineages are elucidated (45). 
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Primary hepatocytes are the most common cellular component in current engineered 
therapies. Most devices undergoing clinical evaluation use porcine hepatocytes, which are 
readily available but, compared with rodent models, are poorly characterized in vitro. 
Whereas some functions such as albumin secretion may be stable, others such as 
cytochrome P-450 decline under standard culture conditions.21,22 In general, primary 
hepatocytes require specific microenvironmental cues to maintain the hepatic phenotype in 
vitro, and continuing investigation of culture conditions is likely to improve the stability of 
primary porcine hepatocytes in vitro as has been the case for rodent hepatocytes. Primary 
human cells are a preferred source for cellular therapies, but like whole organs, they are in 
limited supply.  
Further in vitro characterization of human hepatocytes will provide key information 
affecting the development of improved cell-based therapies. The development of highly 
functional hepatocyte cell lines for use in cellular therapies is an obvious strategy to 
overcome the growth limitations of primary cells. A common approach to immortalizing 
hepatocytes is retroviral transduction of the simian virus 40 tumor antigen gene (SV40 Tag) 
whose gene product binds to cell cycle regulator proteins Rb and p53. Cell lines have also 
resulted from spontaneous immortalization of hepatocytes in collagen gel sandwich cultures 
or co-cultures (37). A third type of hepatic cell line is derived from liver tumors, as in the 
case of HepG2. 
All these cell lines are growth competent but must be evaluated on the basis of liver-specific 
function and safety. Immortalized hepatocytes typically underperform primary cells and 
may not respond to important physiologic cues. The primary safety concern with the use of 
cell lines is the transmission of oncogenic factors to the host, especially with implanted 
cells. Efforts to improve the safety of immortalized cells has resulted in the use of 
temperature-sensitive SV40 Tag,35 Cre–loxP-mediated oncogene excision, and integration 
of suicide genes such as herpes simples virus thymidine kinase (HSV-tk). In the case of 
tumor-derived or spontaneously immortalized lines, limiting patient exposure to cells and 
preventing tumorgenesis may prove more difficult. In addition to primary cells and cell 
lines, stem cells are being considered for use in cellular therapies for liver disease. Stem 
cells are self-renewing cells that have the potential to differentiate into specialized cell 
types. The study of liver stem cell biology is rapidly evolving. Potential stem cell sources 
for use in cell-based therapies are embryonic stem cells, adult liver progenitors, and 
transdifferentiated non hepatic cells. Although embryonic stem cells may ultimately provide 
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a cell source, differentiation along the early hepatocyte lineage in vitro has been reported 
only in murine embryonic stem cells. The oval cell is a “facultative,” bipotential stem cell 
that emerges in the setting of hepatic injury coupled with the inability of the adult 
hepatocyte to undergo repair.42 However, despite the fact that oval cells can be propagated 
in vitro, some transplantation studies indicate that they have less repopulation potential than 
mature hepatocytes. “Progenitor” cells have also been isolated from adult and fetal tissues 
that have not been subject to an oval cell protocol. Certain progenitor cells have been 
characterized as multipotent hepatic stem cells with self-renewal capability in vitro. In 
addition, it appears that hematopoietic stem cells can generate hepatocytes directly as well 
as through an oval cell intermediate, depending on the mode of injury and the model system. 
This has been shown in rodent models and confirmed in humans by a retrospective study of 
recipients of bone marrow and liver transplantation. Although it is not clear which stem cell 
source would be optimal, stem cells that can proliferate yet retain the ability to differentiate 
into hepatocytes would provide an ideal source for engineered cellular therapies. 
Each of the cell sources currently under evaluation, that is, primary cells, cell lines, and 
stem cells, has inherent advantages and limitations. Independent of the source, mature 
hepatocytes in cellular therapies will likely require long-term functional stability to prove 
effective. 
The success of cellular therapies ultimately depends on the stability of the hepatocyte 
phenotype and its regulation by microenvironmental cues. For years, investigators have 
developed culture models based on features of liver architecture to recapitulate the complex 
hepatocyte microenvironment.  These features include extracellular matrix as found in the 
space of Disse, physicochemical stimuli imposed by sinusoidal blood flow, and cell–cell 
interactions present in the hepatic cord. 
Cell–cell interactions, both homotypic (hepatocyte–hepatocyte) and heterotypic 
(hepatocyte–non parenchymal cell), have been shown to improve viability and function. 
Restoration of hepatocyte interactions as in spheroidal aggregates promotes formation of 
bile canaliculi, gap junctions, tight junctions, and E-cadherins and stabilizes function. The 
heterotypic interactions in hepatocyte–non parenchymal co-cultures are thought to present a 
highly conserved signal that greatly augments liver-specific functions. Cell patterning 
methods have been used to study the “co-culture” effect by tightly controlling the amount of 
cell–cell interaction to identify specific signaling pathways. Whatever the nature of the 
hepatocyte therapy, the issue of phenotypic stability must be addressed. Elucidation of 
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specific molecular mechanisms that stabilize hepatocyte function would have broad impact 
in this field. 
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Chapter 2:  Aims of work and Cellular Models  
 
2.1 Aims of the work 
The need to regenerate functional liver tissue in vitro concerns several areas of bio-
engineering application e.g. model tissue for drug testing, bio artificial liver supports and, 
finally,  potentially engineered organs for implantation into patients.  
Liver showed a complex and peculiar architecture, to study the single events that induce 
liver  organization, functions and disease, is necessary to obtain a single cellular models for 
understand a single role in physiology and pathologic conditions. 
We dispose of peculiar tools to in vitro study of the physiological cellular interplay in the 
liver:  
i) the differentiated murine hepatocytes cell lines MMH, a wide range proteomic 
analysis highlighted as confluent MMHs also retain “in vivo features” in terms 
of cell-cell contact influences on proliferation and differentiation. 
ii) in addition, we recently reported the isolation, characterization and reproducible 
establishment in line of  resident liver stem cells (RLSCs) with 
immunophenotype (Sca1+, CD34-, CD45-, Alpha-fetoprotein+, Albumin) that 
locate them in a pre-hepatoblast/liver precursor cells hierarchical position and 
differentiative potentiality spanning from endodermal to mesenchymal and 
ectodermal derivatives. (Conigliaro et al., 2008). 
 
To perform in vitro approaches of liver bioengineering, it is also necessary to dispose of 
sinusoidal endothelial cells, being liver endothelium a prime example of organ-specific 
microvascular differentiation and functions. 
The liver endothelial cells, that form the lining of the hepatic sinusoids, represent a 
morphologically and functionally unique sub-population named liver sinusoidal endothelial 
cells (LSECs). Considering that endothelial primary cells are difficult and time–consuming 
to isolate, limited in number, invariably contain impurities with other cell types, and may 
lack the features of pathologic vasculature, the in vitro study of endothelial-specific 
functions has been hampered up today. Many authors tried to obtain an in vitro cellular 
model by immortalization strategies on freshly isolated SECs (immortalization with SV40 
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Middle T or Large T antigens), nevertheless these approaches failed inducing aberrant 
activation of endothelial-specific pathways. 
 
Our efforts have been focused to the isolation and establishment in line of a liver sinusoidal 
endothelial cell  and to the characterizations of resident liver stem cells line 
i) to dispose of an in vitro system for the identification of critical microenvironment factors 
involved in liver cellular interplay during physiology or pathology conditions and 
 ii) to possibly improve protocols of liver tissue engineering.  
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2.2 Met Murine Hepatocytes: MMH soluble factors are able to maintain 
sinusoidal endothelial cells in differentiate state. 
 
Met Murine Hepatocytes (MMHs) are immortalized cell lines derived from explants
 
of 
embryonic, fetal, and new-born liver derived from transgenic
 
mice expressing a 
constitutively active truncated human Met receptor
 
(cyto-Met) under control of the human 
1-antitrypsin transcription
 
unit (2). Although the immortalization of
 
transgenic liver cells 
was reproducible, the event was rare: a
 
small number of epithelial islands emerged and grew 
from a large
 
number of cells in the primary cultures (Amicone L. et al., 1997).  Making use 
of the MMH hepatocytes cell model we demonstrated the influence of soluble factors in 
conditioned medium released by murine hepatocyte conditioned medium (MH-CM) on 
human CB CD34+ progenitors (7); in long- term MH-CM culture we obtained growth of: (i) 
a bulk CD34+ population differentiating toward the endothelial lineage and (ii) single 
CD34+ cells expressing both haematopoietic (CD45) and endothelial (CD144) markers. In 
recent our studies, we explored the potential of human CB CD34+ HPCs to differentiate into 
haemogenic endothelium. In long-term culture, the addition of MH-CM stimulates the initial 
CD34+45+144− HPCs to generate adherent CD45−144+ endothelial precursors capable of 
self-renewal/proliferation and to differentiate in endothelial cells in vivo. These cells, 
instructed by haematopoietic growth factors (HGFs), rapidly differentiate into CD45+144+ 
cells that in turn generate either (i) CD45+ haematopoietic cells (mainly of erythroid and 
megakaryocytic type) when grown in haematopoietic medium, or (ii) CD144+ ECs if 
cultured in endothelial medium (59). 
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Figure 5. Immunophenotypic and morphological analysis of adherent ECs progeny following transfer into haematopoietic culture. 
A- Left: Time course FACS analysis of adherent cells generated by CD34+ cells cultured in MH-CM and then transferred, at day 30, to 
haematopoieticmedium and characterized for lineage -specific antigen expression. A representative experiment out of 5 is shown. - Right: 
Growth curve of erythroid (E) and megakaryocytic (Mk) cells generated from the culture of day- 30 adherent cells in haematopoietic medium. A 
representative experiment out 
of 5 is shown. B- Morphological analysis of adherent cells generated by CD34+ cells cultured in MH-CM for 30 days, then transferred to 
haematopoietic medium and grown for additional days (day 30 = day 0 in haematopoietic medium, day 40 = day 10 in haematopoietic medium, 
day50 = day 20 in haematopoietic medium, day 60 = day 30 in haematopoietic medium). At day 40, the large majority of cells had a morphology 
typical of the erythroid lineage elements at various stages of maturation. At later days of culture (day 50 and 60), erythroid cells were replaced by 
a cell population with a morphology compatible with the cord blood derived megakaryocytes (i.e. showing limited capacity of polyploidization). 
Pictures of a representative experiment out of 3 are shown. C- CD144 and CD45 expression analysis of adherent cells generated by CD34+ cells 
cultured in MHCM for 30 days, then transferred to haematopoietic medium (i.e. day 33 = day 3 in haematopoietic medium, day 36 = day 6 in 
haematopoieticmedium and so on). The percentage of CD144+452, CD144+45+ and CD144245+ cells from 8 independent experiments is 
reported (mean values 6SEM ). 
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2.3 Murine Resident Liver Stem Cells (RLSCs) 
 
In this study we also made use of an immortalized liver progenitor cell line isolated in our 
laboratory among the MMH lines (Spagnoli, F.M., et al., 1998). The MMH lines are 
composed of two distinct cell types:
 
the expected epithelial cells as well as a cell type of 
spreading
 
fibroblast-like morphology that we designate palmate. The epithelial
 
cells express  
LETFs (Liver Enriched Transcription Factors). In addition,
 
many express hepatic functions, 
or are competent to do so
 
upon induction. In contrast, the palmate cells express neither
 
LETFs nor hepatic functions. We demonstrated that palmate cells show properties of 
resident liver stem cells, or RLSC (14). The palmate RLSCs are bipotential progenitors 
(Sca1
+
, CD34
-
, CD45
-
, α-fetoprotein+, Albumin-) that give rise to epithelial cells of both 
hepatocyte and cholangiocyte lineages, spontaneously upon continuous
 
culture, or 
precociously under the appropriate environmental conditions.
 
Epithelial progeny of palmate 
cells express LETFs and are competent
 
to express hepatic functions. In addition, in three-
dimensional
 
cultures, palmate cells form hollow tubules lined with microvilli,
 
reminiscent of 
bile ducts. Unequivocal demonstration that palmate cells can give rise to epithelial-
hepatocytes is provided by cloning of individually
 
fished cells and characterization of their 
progeny. All of these findings demonstrate
 
that palmate cells are the precursors of 
hepatocytes in MMH cell
 
lines.  
Interestingly, RLSCs  display a peculiar transcriptome profile, with coexistence of epithelial 
and mesenchymal markers (32). Such metastable phenotype, peculiar to stem cells, is 
perpetuated over cell generations in absence of any instructive signal and in basal culture 
conditions.   
Recently, we demonstrate that RLSCs are able to differentiate in vitro and in vivo 
(orthotopic transplants and heterotopic transplants) in epithelial and mesenchymal 
derivatives, thus suggesting for the first time the existence of an adult stem/precursor cell 
capable of providing both parenchymal and non-parenchymal components to a complex 
epithelial organ (Conigliaro et al., submitted).  
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Chapter 3: MATERIALS AND METHODS 
 
3.1  In vitro studies  
 
Primary sinusoidal endothelial cell culture 
Primary culture were performed in accord to previously described protocol (DELEVE) [91] 
with some modifications. Briefly, LSECs were isolated from CD1 mice by enzymatic 
digestion (Collagenase IV SIGMA Cat.C5138, Pronase SIGMA Cat.P6911 , DNAsi IV 
SIGMA Cat.D5025, Ialuronidase IV SIGMA Cat.H6254), percol discontinues density 
gradient centrifugation and centrifugal elutriation. The  centrifugation method permit the 
separation of non parenchymal and parenchymal cells fractions. Sinusoidal endothelial cells 
was comprise in non parenchymal cells fraction. This fraction was maintained in different 
culture conditions: plated at high density on and not collagen I (Transduction Laboratories, 
Lexington, UK) coated dishes (Falcon-BD, Franklin Lakes, NJ) on in hepatocyte conditional 
medium (MH-CM), RPMI-1640, supplemented with 10% Foetal Bovin Serum (FBS)  (both 
Gibco, Carlsbad, CA), 50 ng/ml Epidermal Growth Factor, 30 ng/ml Insulin like Growth 
Factor II (PeproTech Inc, Rocky Hill, NJ), 10 g/ml insulin (Roche, Mannheim, Germany), 
2 mmol/L L-glutamine, 100 g/mL penicillin and 100 g/mL streptomycin (Gibco); 
Dulbecco’s Modified Eagle’s Medium (DMEM) containing 10% FBS (basal medium); 
IMDM containing 10% FBS. After 12-24 hours the cultures were washed to remove all 
unattached cells and medium replaced. The cultures were maintained without transfer for 
several weeks with medium replacement twice a week. Within 4 weeks of culture, only cells 
plated on in coated dishes in MH-CM were survived and colonies with distinct cell 
morphology became visible; these cells are named “mix populations” 
After sub cloning, we found a single  sinusoidal endothelial cell clone that is maintained 
only on in MH-CM in  collagen I coated dishes. 
 
Immortalization strategies 
Mix populations were immortalized by two different strategies: spontaneously (END S) and 
retroviral transduction (END M). For the first strategy the cells were plated in coated dishes 
on in MH-CM with medium replacement twice a week. 
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For the second strategy, cells were immortalized using a pantropic lentivirus to overexpress 
the SV 40 middle T-antigen. Briefly, viral supernatant containing high-titer SV40 virus was 
diluted 1:2 in culture media and added to mix populations 24h after plating. Cells were 
incubated for 48h, and then washed and cultured in MH-CM for 24h. 
Within 4 weeks of culture, cells were characterized by FACS for CD105, MECA32, CD144, 
LYVE1. 
 
Adenoviral transduction of Cell Culture 
Primary mix populations were cultured in the presence of adenoviral vectors carrying green 
fluorescent protein (EGFP). Cultures were analyzed at 48h by FACS analysis. 
 
Single cell cloning 
In order to obtain clonal cell lines we performed limiting dilution seeding cells in 
microtitration plate at a concentration of 0,1 cell/well. Passages are calculated from initial 
thawing. 
The medium replacement twice a week. Within 40 days of culture, we obtained 6 clones 
from END M and  4 clones from END S. After, these clones were expanded in cultures on 
in MH-CM and EGM-2 (endothelial instructive medium). Both cells were analysed for 
sinusoidal endothelial cells markers by FACS and Real Time PCR. 
 
3.2 In vivo Studies:  
 
Animals care and treatment 
Animal management and experiments were performed according to the criteria outlined in 
the ‘Guide for the Care and Use of Laboratory Animals’ of the National Academy of 
Sciences and published by the National Institutes of Health (NIH publication 86–23 revised 
1985). 
 
Orthotropic transplantation 
CD1 newborn mice (2 days after birth) were transplanted, by transcutaneous injection into 
the liver (i.h.), with 1x10
6
 EGFP/LSECs or EGFP/RLSCs in 15ml PBS using a 30-gauge 
needle (Hamilton Bonaduz AG,Bonaduz, Switzerland). 
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Mice were sacrificed by cervical dislocation after 60 days and the livers removed, formalin 
fixed, mounted onto OCT and cooled by liquid nitrogen.  
 
Heterotopic transplantation in GF-reduced Matrigel  
Mouse sinusoidal endothelial cells (LSECs) cells or resident liver stem cells (RLSCs) (1 
x10
6
) were suspended in 1ml of Matrigel Growth factor-reduced (BD Biosciences Labware, 
San Diego, CA ) with an equal quantity of mouse resident liver stem cells in differentiate 
state (RLSCdH) or Huvec for RLSCs transplants. Aliquots of about 0,7 ml of suspension 
were injected subcutaneously in the back of skid beige mice (Charles River Laboratories, 
Raleigh, NC, U.S.A.), carefully positioning the needle between the epidermis and the 
muscle layer. Mice were sacrificed by cervical dislocation after 21 days and transplants 
were immediately fixed for histology. 
 
3.3 Cell and tissue analysis 
 
RNA extraction, Reverse Transcription and Real Time quantitative PCR (qRT-
PCR) 
Total RNA was extracted from cultured cells using TRIzol reagent (Invitrogen, San Diego) 
according to the manufacturer’s instructions. For RT-PCR analyses, single-stranded cDNA 
was obtained by reverse transcription of 1μg of total RNA using MMLV-reverse 
transcriptase (Promega, MI, Italia). cDNA was amplified by PCR using GoTaq enzyme 
(Promega, MI, Italia).  
qRT-PCRs were performed using Rotor gene 6000 series. The Light Cycler Fast Start DNA 
Master SYBR Green I (Roche) was used to produce fluorescent-labeled PCR products 
during repetitive cycling of the amplification reaction. 40 ng of cDNA was used as template 
and cycling parameters were 95°C for 3 min, followed by 45 cycles of 95°C for 30s, 60°C 
for 1 min, 72°C for 30s, 60°C +0,5°C for 10 min. Fluorescence intensities were analyzed 
using the manufacturer's software and relative amounts were obtained using the 2–ΔΔCt 
method and normalized for the -actin. For a list of specific primers see following table 
(table 1). 
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Table 1. Mouse oligonucleotides used for quantitative real-time RT-PCR 
 
Mouse-ACTIN 5’- ACCACACCTTCTACAATGAG-3’ 
5’- AGGTCTCAAACATGATCTGG -3’ 
Mouse IL 6  5’-CACCAAGAACGATAGTCA A-3’ 
5’-TTTCCACGATTTCCCAGA-5’ 
Mouse KDR (VEGFR2) 5’-GCTGAAGATAATGACTCACC-3’ 
5’-CTGTGATGATGTAAATGGGAC-3’ 
Mouse CD144 5’-TAGCAAGAGTGCGCTGGAGATTCA-3’ 
5’-ACACATCATAGCTGGTGGTGTCCA-3’ 
Mouse vWF 5’-TGGCAAGAGAATGAGCCTGTCTGT-3’ 
5’-TAGGGCATGGAGATGCTTTGGTCA-3’ 
Mouse CD31 5’-ACCTGTAGCCAACTTCACCATCCA-3’ 
5’-TCTCCTCGGCGATCTTGCTGAAAT-3’ 
Mouse ANGPTL3 5’-AACAAGATGACCTTCCTGCCGACT-3’ 
5’-TGGACTGCCTGATTGGGTATCACA-3’ 
Mouse STABILIN2 5’-AAACTCCAGTGCAAATGCCTTCCC-3’ 
5’-ACTGGCAGACACACTTGACCATCT-3’ 
 
 
Immunofluorescence 
Formalin-fixed frozen liver tissues were sliced (7M) and stained with: anti-GFP Ab 1/200 
(Santa Cruz Biotechnology sc-8334), anti-EGFP aB 1/600 (Abnova MAB1765), anti-
HNF4 Ab 1/100 (Abcam ab41898), anti-Albumin Ab 1/200 (Novus Biologicals ab19196), 
anti-PanCytokeratin Ab 1/500 (Dako z0622), anti-Cytokeratin 7 Ab 1/200 (Abcam ab9021), 
anti-Desmin Ab 1/200 (Thermo Scientific RB-9014), anti-GFAP Ab 1/200 (Millipore 
MAB3402), anti CD31 Ab 1/200 (BD Biosciences 55027), anti- PDGFR2 ab1/300 (LS bio- 
LS-C106587)  anti-EpCAM Ab 1/200 (BD Biosciences 552370), anti FetoProtein Ab 
1/200 (Santa Cruz Biotechnology sc-8108), anti E-Cadherin Ab 1/50 (BD Biosciences 
610181), anti SMA Ab 1/200 (Sigma-Aldrich A5228). 
Secondary antibodies (Alexa-Fluor 488 and Alexa-Fluor 594 diluted 1/500) were from 
Molecular Probes, Eugene, OR, USA. The nuclei were  co-stained with TOPRO3 
(Invitrogen). Preparations were examined  with a Leica TCS2 confocal microscope. 
From heterotopic transplant sections, 5m thick, embedded in paraffin were stained with 
hematoxylin and eosin. Immunolocalization was performed using standard 
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immunoperoxidase (DAB reaction) and counterstained with hematoxylin.  
For immunocytochemistry, cells were grown on collagen I-coated dishes, fixed and treated 
as described previously. 
 
 
Flow cytometry 
Cells were trypsinited and pellets were suspended following two protocols, one for 
membrane proteins and one for the cytosol proteins. For the membrane proteins: pellets 
were suspended with antibody diluted 1:50 in PBS1, BSA, sodium azide, and incubated for 
20 minutes at 4°C darkness. After cells were suspended with 100l of buffer and 
centrifugated; final cell pellet were suspended in FACS flow buffer or in its addition with 
100l of PAF1%. 
For the cytosol proteins: cells pellet were suspended with antibody diluted 1:50 in PBS 1x, 
Saponine 0,1%, BSA, sodium azide  for 20 minutes at 4°C darkness. After pellet suspended 
in PBS, BSA, 0,1% saponine, sodium azide and centrifuged. Final pellet were suspended in 
FACS flow buffer or in its addition with 100l of PAF1%. Cell fluorescence was analyzed 
with the FACSCalibur (Becton Dickinson). 
For a list of specific antibodies see following table (Table 2). 
 
 
Table 2. Mouse antibodies used for FACS analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
PE anti mouse CD 105 eBioscience-cat. 12-1051-81 
APC anti mouse CD144 eBioscience-cat. 17-1441 
Biotin Rat Anti-Mouse Panendothelial Cell 
Antigen 
BD Bioscience-cat. 558773 
Anti-Mouse Lyve-1 Alexa Fluor® 488 eBioscience-cat. 53-0443-80 
FITC Anti mouse CD31  eBioscience- cat.11-0311-82 
PE anti mouse ALCAM (CD166) eBioscience- cat.12-1661-82 
FITC Rat anti mouse Ly-6A/E  BD Bioscience- cat.557405 
Anti mouse-VIMENTIN FITC eBioscience- cat.11-9897-80 
Anti mouse VEGFR 1 ReD system-cat. MAB4711 
PERCP-e Fluor 710 
 anti mouse CD324 (E-CADHERIN) 
eBioscience- cat.46-3249-80 
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Tube formation assay 
Vascular tube formation assay were performed on growth factor-reduced Matrigel (BD 
Bioscience, Bedford, MA ; USA). Briefly, MLECs were trypsinized and seeded onto the 
Matrigel (10.000cells/well) in the presence of MH-CM or EGM-2. Random fields were 
photographed at 2h-4h-6h after seeding. Vascular tube formation was assessed with optic 
microscopy. 
 
SEM analysis 
Scanning electron microscopy was performed to studies the presence of fenestrate on c. 
Cells were fixed in 2.5 gluteraldehyde for 1h, post-fixed in 1%osmium tetroxide on ice 
30min, dehydrated,critical point dried, sputter or carbon coat, and image at 3kV using S-
4700 scanning electron microscope (Hitachi). 
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Chapter 4: Resident liver stem cells (RLSC) result’s 
 
4.1 RLSC coexpress epithelial and mesenchymal markers and undergo into 
mutually exclusive differentiations 
 
Two RLSC lines, WTE14/1and MetE14/3, initially isolated from explants of embryonic 
livers at 14 days post coitum and previously characterized for their broad differentiation 
capacity 15, have been seeded at clonal limiting dilution (0,2 cell/well ) and expanded. A 
single clonal progeny from each of the two lines (WTE14/1-1 and MetE14/3-1) was 
randomly selected and used as starting populations for these studies; the results obtained in 
cell culture and in vivo experiments and described below were equivalent for the two clones 
that, from now on, will be referred to simply as RLSCs. 
FACS analysis of the starting undifferentiated RLSC clones revealed as the cells 
homogenously express the stem marker SCA1 and, notably, co-express epithelial and 
mesenchymal markers such as E-Cadherin, PanCK and Vimentin (Figure 1A). An 
immunocytochemical analysis confirmed the co-expression of these proteins (Figure 1B) 
unveiling for E-Cadherin a cytoplasm distribution. A broader characterization by FACS 
analysis showed that cells were negative for CD144, CD45, and Thy1 (data not shown) so 
excluding an hematopoietic origin. 
Surprisingly, low serum culture condition gave rise, within the same culture, to cells with 
either epithelial or mesenchymal morphology (Figure 1C). The unexpected appearance of 
two morphologically discrete subpopulations within a clonal cell line rendered mandatory to 
gather observations at single cell level. To this end we marked RLSCs with a retrovirus 
expressing enhanced green fluorescent protein (EGFP) and followed single cells 
proliferation/differentiation by live imaging. This analysis allowed to re-conduct the 
dimorphism to single mother cells: as shown in Figure 1D and in the supplementary video, 
single EGFP-RLSC followed for 5 days gave rise to cells either co-expressing E-Cadherin 
and Vimentin or expressing one of these two markers in a mutually exclusive fashion. 
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Figure 1. RLSC characterization and in vitro differentiation. 
A) FACS analysis for the indicated antigens highlighted as the RLSC starting population homogeneously expresses the stemness marker SCA1, 
the epithelial markers Pan-CK and E-cad and the mesenchymal marker Vimentin. 
B) Immunocytochemical analysis for the indicated markers highlighted as the RLSC starting population co-expresses epithelial and 
mesenchymal markers. 
C) Within 10 days RLSCs, in low serum culture condition, gave rise to derivatives that acquired distinct epithelial and mesenchymal phenotypes 
as observed by phase contrast (original magnification 20X). 
D-E) Time lapse analysis (see also video1) indicates as, within five days, a single EGFP-RLSC cell, cultured in low serum, gave rise to clonal 
progeny composed by cells co-expressing Vimentin and E-cadherin (yellow arrows), cells expressing E-cadherin (blue arrow) and cells 
expressing Vimentin (red arrow). 
 
 
To further characterize the segregation of epithelial and mesenchymal markers to different 
cell populations, a dimorphic cell culture, obtained at confluence after 10 days of starvation, 
was analyzed by FACS and immunofluorescence. FACS analysis highlighted that cells 
undergoing to epithelial differentiation down-regulate both stem and mesenchymal markers, 
while cells undergoing to mesenchymal differentiation down-regulate both stem and 
epithelial markers (Figure 2A). Immunofluorescence analysis for Vimentin/E-Cadherin and 
for a-SMA/HNF4 highlighted as cells express these markers in a mutually exclusive fashion 
and in coherence with the corresponding cellular habit. The epithelial-shaped progeny was 
further characterized as expressing the HNF4 while the mesenchymal-shaped one as 
expressing the myofibroblast-associate marker α- smooth muscle actin (αSMA) (Figure 2B). 
Quantitative analysis of markers segregation is shown in figure 2C. 
These results indicate an intrinsic dual differentiation potentiality of RLSCs. 
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Figure 2. Segregation of epithelial and mesenchymal markers into distinct RLSC derivatives. 
A) Immunocytochemical analysis for the indicated markers highlighted as RLSCs, cultured in low serum for 10 days, undergo into either 
epithelial or mesenchymal differentiation. The morphology of the two different cellular subpopulations is coherent with the expression of 
specific markers. 
B) Cells were scored in four categories based on their Vimentin and E-Cadherin expression. Data show percentage of cells for each category. 
Average of 3 experiment. N=500 cells were counted for each experiment. Data are shown as mean ± SEM. 
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4.2 RLSC derivatives display liver-specific epithelial and mesenchymal 
phenotypes in orthotopic transplant 
 
To challenge in vivo the intrinsic dual differentiation potentiality of RLSC, EGFP+ cells 
were injected directly into the liver of untreated immuno-tollerant (CD1) mice at the first 
day after birth, through a percutaneous trans-abdominal puncture, according to Bissig et al. 
17. Animals were sacrificed at various times and the peak of colonization was found around 
two months after cell transplantation. RLSC progeny, only capitalizing on the differentiating 
and proliferative stimuli of the growing organ and in competition with endogenous cells, 
was found to reproducibly colonize the recipient livers in 40/50 injected animals. In 30 
animals, EGFP+ cells expressing hepatocyte markers (i.e. the transcription factor HNF4α 
and Albumin) engrafted in the hepatocytic muralium with an efficiency until 0.01% of total 
hepatocytes (Figure 3 A). 
 Notably, in each of the 40 engrafted mice, EGFP+ cells with a mesenchymal shape and 
expressing Glial Fibrillary Acidic Protein (GFAP) and Desmin were also observed (Figure 3 
B). The sub-endothelial localization of these cells (in peri-sinusoidal spaces, Figure 3C), 
together with their immunophenotype, corresponds to those of Hepatic Stellate Cells. 
Taken together, these data indicated that clonal RLSCs could contribute to both epithelial 
and mesenchymal specific compartments of the liver. 
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Figure 3.Characterization of RLSC derivatives in orthotopic transplants. 
Immunohistochemical analysis of RLSCs engrafted livers. The RLSC’s EGFP progeny was detected in untreated CD1 null mice injected at 2 
days after birth and sacrificed after two months. 
A- EGFP parenchymal cells were found either integrated into the epithelial cords expressing hepatocyte markers HNF4 and Albumin. 
B-  EGFP non- parenchymal cells expressing GFAP and Desmin were found both scattered in the parenchyma and C) in sub-
endothelial positions. The endothelium was decorated with CD31antibody. 
 
 
4.3 RLSC give rise to liver-specific epithelial and mesenchymal derivatives in 
heterotopic transplants 
 
In order to determine to what extent the differentiation of transplanted progenitors into 
hepatic lineages was induced by liver-specific local cues, EGFP+ RLSCs were transplanted 
subcutaneously into the back of SCID beige mice, as described in Methods. The co-
transplants with Huvec cells was performed in order to guarantee an homogenous 
vascularization inside the implant. 
Histological and immuno-histochemical analysis of implants showed RLSC derivatives with 
both epithelial and mesenchymal phenotypes (Figure 4A); these cells were found to express 
a number of liver histotype-restricted markers including EpCAM, α-fetoprotein, E-Caderin, 
CK7, Albumin, detected in cells with epithelial morphology, and GFAP and α-SMA, 
observed in those displaying mesenchymal shape. (Figure 4B-C). The expression of 
EpCAM and α-fetoprotein (endodermal precursor markers), in particular, suggests that in an 
extra-hepatic context, RLSC derivatives proliferate retaining precursor features; moreover 
the low expression of Albumin and CK7 indicates also the RLSC aptitude to differentiate 
toward hepatocytes/cholangiocytes. With respect to mesenchymal differentiation, the 
expression of α-SMA and GFAP suggested that the ability of RLSCs to generate a HSC-like 
phenotype was also inherent and independent of exogenous, liver restricted cues. Overall, 
heterotopic transplantations highlighted that RLSCs retain a binary, mesenchymal-epithelial 
potential, independent of soluble factors, cell-to-cell and cell-to-ECM organ-specific 
instructive signals. Taken together these results indicate an intrinsic dual potential of RLSCs 
to differentiate into either epithelial or mesenchymal derivatives. This dual potential, per se 
cell-autonomous as reproduced in cell culture, may harness organ-specific cues in vivo, 
critical for proper maturation toward liver-specific cell types. 
 
 58 
 
 
 
Figure 4. Characterization of 
RLSC derivatives in heterotopic 
transplants. 
H&E Immunohistochemical and 
Immunofluorescence analysis of 
RLSCs engrafted in SCID adult 
null mice. RLSCs were injected in 
Matrigel in the epifascial region and 
animals were analyzed one 
month after injection. 
A) H&E revealed epithelial-like 
RLSC derivatives found either 
arranged in compact islands or 
delimiting empty spaces. 
Mesenchymal-like RLSC derivatives 
were found scattered in the matrigel 
scaffold. 
B) The EGFP epithelial cells were 
found to express the hepatic 
progenitor/hepatocyte markers, 
EpCAM, αFP, E-Cad, Albumin and 
CK7. 
C) The EGFP mesenchymal cells 
were found to express GFAP and 
αSMA by IF and IHC (bottom 
panel). 
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Chapter 5: Sinusoidal Endothelial Cells result’s 
 
5.1 Characterization of elutriated non parenchymal cells (NPC) 
 
Primary cultures were prepared from livers of mice CD1 14 days post coitum. LSECs were 
isolated by enzymatic digestion of the liver with Collagenase IV, Ialuronidase IV, DNAsi 
IV and Pronase, and Percol discontinues density gradient centrifugation. Cell elutriation 
procedure was performed to separate parenchymal from non parenchymal cells, including 
sinusoidal endothelial cells. Non parenchymal cell fraction was cultured in hepatocytes 
conditional medium (MH-CM) (Figure 1A) and after 15 days analysed by FACS for 
expression of endothelial markers. 
FACS analysis showed that 15% of cells express both the endothelial markers CD105 and 
MECA 32. Less of than 7% of cells express the mesenchymal progenitor markers, ALCAM 
(Figure 1B), this indicating the presence of progenitor cells in non parenchymal fraction. 
Notably, after 2 weeks of culture the cells have been shown to be capable of forming tubular 
structures spontaneously (i.e. without instructive stimuli), as wells as the well-differentiated 
endothelial cells. (Figure 1C-C’). 
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Figure 1. Immuno-phenotypic and morphological analysis of non parenchymal cells fractions (NPC). 
 
A- Left: Morphological analysis of non parenchymal cells maintained on in MH-CM in collagen I coated dished. 
B- FACS analysis of non parenchymal cells. We analysed sinusoidal endothelial marker, MECA 32; endothelial markers: CD105 and 
CD144;  mesodermal progenitors marker ALCAM. 
C-  Right: Morphological analysis of non parenchymal cells. Cells are able to form spontaneously tubules in collagen coated dished. 
          Imagines acquired to original magnifications 20X  (the first line of images)and 40X (the second line of images). 
 
 
 
5.2 Establishment and characterization of non parenchymal cell lines 
 
The mix populations of non parenchymal cells were immortalized by two different 
strategies: 
1) cells were left for 14 days in MH-CM, until immortalized elements emerged from 
senescent cultures (spontaneously immortalized endothelium, END S); 
2) cells were infected with  a pantropic lentivirus carrying the SV 40 middle T-antigen 
(Middle T immortalized endothelium, END M).  
 
 Immortalized cells were immunophenotypic characterized by FACS. 
The characterization showed that  END S and END M express the typical endothelial 
marker CD105 together with the markers of sinusoidal fenestrae MECA 32,  LYVE1, 
(Figure 2A). 
Notably, both populations do not express typical endothelial marker CD144; this is in line 
with many studies suggesting that this protein is not essential to function of liver sinusoidal 
endothelial cells, in which its expression is strictly related to the age. 
 
 Both immortalized cell lines required collagen as substrate. 
 END M cell line, as direct consequence of the transforming middle T antigen expression, 
has a doubling time shorter than END S  (data no shown). 
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 To explore the tumorigenicity of both cell lines, END M and END S marked with a 
retrovirus expressing EGP,  were transplanted subcutaneously in SCID mice.  No 
tumours development was observed for both cell lines after 4 weeks from the 
transplantation. 
     (Figure 2B). 
 
 
Figure 2. Immunophenotypic and morphological analysis of END M and END S. 
 
A- Left: FACS analysis of mother populations END M (immortalized by SV40 Middle T antigen ) and END S (spontaneously 
immortalized endothelium). Cells characterized for endothelial markers: CD105, CD144; and sinusoidal endothelial markers MECA 
32 and LYVE 1. 
B- Right: Histological analysis of Heterotopic transplants. END M and END S were transplanted subcutaneously into the  SCID mice. 
Mice were sacrificed by cervical dislocation after 21 days and transplants were immediately fixed for histology. Both mother 
populations not shown a tumorigenic capability. 
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5.3 Establishment and characterization of clonal endothelial cell lines. 
 
In order to obtain single sinusoidal endothelial clones expressing SECs features, we 
performed a cloning assay by limiting dilution of  END M and END S cells. 
After 40 days of culture we obtained 6 clones from END M cells (named M1,M2,M4,M6) 
and 4 clones from END S (named S1,S2,S3,S4) (Figure 3A).  
Characterization of two immortalized clonal cells END M and END S were performed 
comparing two different culture conditions, MH-CM and EGM 2. This is an endothelial 
instructive medium, normally used for the maintenance of endothelial cells culture; it is 
added with angiogenic growth factors, as VEGF, FGFb; ascorbic acid and EGF. 
 
 Immuno-phenotypic characterization by FACS analysis revealed as all clones 
express markers even if at different levels: in both cultured conditions, all clones 
showed high levels of CD105, MECA 32, LYVE1 and CD144. Interestingly, only 
when clones were cultured in MH-CM showed approximately 96% positive cells for 
all sinusoidal endothelial markers (Figure 3B).  
 
 To investigate on the endothelial functions we performed a tubulogenesis assay in 
the same culture conditions. Clones cultured in MH-CM are able to form tubules in 
only 4 hours respect to clones cultured in EGM2, in which we observed tubules 
after 6h from the seeding (Figure 4). In particular, between all clones, the S2 clone 
show a better capability to form tubules in vitro, in terms of structure and quantity, 
in both experimental conditions. 
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Figure 3. Immuno-phenotypic of clones derived from END S and END M populations 
 
A- FACS analysis of clones generated by END M cells: M1-M2-M3-M4, and clones generated by END S cells: S1,S2,S3,S4.  Cells  
cultured in MH-CM and characterized for lineage -specific antigen expression. Clones showed, in particular, a variable expression 
of specific sinusoidal endothelial markers, Lyve 1 and Meca32 
B- FACS analysis of clones cultured in different medium as MH-CM and endothelial instructive medium EGM-2 for 15 days. Cells 
showed a high expression of sinusoidal endothelial markers in presence of hepatocytes soluble factors. In particular, S2 clone had a 
typical sinusoidal endothelial phenotype. 
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Figure 4. Tube formation assay. Inverse microscopic images illustrating  
clones maintained in MH-CM (A-A’-A”-A”’) and clones maintained in 
EGM 2 (B-B’-B”-B’”) and put in matrigel for different duration of 
cultivation. Imagines acquired when cells showed better tubes formation. 
Original magnification 20x. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
.  
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 Furthermore, by the use of Scanning Electron Microscopy we evaluated  the 
number and dimensions of cytoplasmatic  fenestrae, typical of sinusoidal endothelial 
structure. We observed  fenestrae with a mean diameter of 60-100nm only in clones 
cultivated in MH-CM (Figure 5). 
 
 
 
Figure 5.SEM analysis. We evaluated cell morphologic by SEM ,of  clones S1 (A-B-C) , S2 (A’-B’-B’), M4 ( A’’-B’’-C’’),  
M6 (A’’’-B’’’-C’’’) maintained in MH-CM. We found the fenestrature with following diameters: 
S1(A-B-C) : 60-100nm 
S2 (A’-B’-B’): 50-80nm 
M4 ( A’’-B’’-C’’): 50-100nm 
M6 (A’’’-B’’’-C’’’): 50-100nm 
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 In order to explore the angiogenesis capability in vivo we performed  heterotopic 
transplants. The clones were co-transplanted  with hepatocytes subcutaneously into 
SCID mice.  
 
Firstly, we observed that clones derived from END M (M4, M6) acquired tumorigenicity 
capability (Figure 6B), while those derived from spontaneous immortalization events are not 
transformed and organize themselves in tubular structures driving correctly the architectural 
organization of co-transplanted hepatocytes. In particular, END S clones are able to forms 
vessels, as shown by CD31 expression, and  to induce an organization of hepatocytes in 
cords highly reminiscent of the epithelial muralium in the liver (Figure 6A).  
In the tumoral tissue formed starting from END M clones, we observed a disorganized 
vessel system unable to drive a correct hepatocyte organization. 
 
Over all, the endothelial cell lines characterization showed as hepatocyte soluble factors 
play a pivotal role in the maintenance of sinusoidal endothelial cells phenotype and 
functions. 
 
All further studies were performed with S2 clone, because it showed a better phenotype and 
endothelial features in vitro and in vivo 
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Figure 6. Heterotopic transplants. H&E Immunohistochemical and Immunofluorescence analysis of sinusoidal endothelial clones co-injected 
with hepatocytes in SCID adult null mice. Cells were injected in Matrigel in the epifascial region and animals were analyzed one month after 
injection. 
A- Clones cells were found to express the endothelial marker CD31,as shown in red spot. (A’-A’’-A’’’) .Hepatocytes were identified 
by the  E-cadherin expression (as shown in green spots) near endothelial clones CD31 positive, as shown by images.  
B- Sinusoidal Endothelial clones derived from END S showed a non-tumorigenic aptitude, while cell clones derived by END M 
showed a strong tumorigenic capability. 
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5.4 Liver endothelial cells are able to maintain the differentiate state in vitro  
 
S2 clone  is now named MLECs from Mouse Liver Endothelial Cells. 
A further  immunophenotypic characterization of MLECs cultured in  MH-CM (M-MLECs) 
and in EGM2 (E-MLECs) were performed. 
 
FACS analysis showed as cells cultured in hepatocyte conditional medium were 
approximately 100% positive for the sinusoidal  endothelial markers. 
In particular cells maintained in MH-CM were: 96% positive for MECA 32 and 2% positive 
for Lyve 1,  typical markers of fenetrature, respect same cells in EGM 2 in which they were: 
90% positive for MECA32 and 5% positive for LYVE.1.  
Notably, we showed  in both cells (M-MLECs and E-MLEC), different levels of expression 
of typical endothelial markers; in fact in presence of MH-CM cells were 96% double-
positive to CD144/CD31 and 97% positive to CD105, respect in EGM2 in which cells were 
76% double-positive CD144/CD31 and 75% positive to CD105. 
 
These data were confirmed by RT-qPCR analysis, in which observed high levels of mRNA 
expression of CD144 and CD31 in presence of hepatocyte soluble factors.  
Interestingly, mRNA expression of liver endothelial and endothelial specific genes were 
increased in presence of MH-CM respect in the EGM2, such as KDR, vWF for endothelial 
markers and Stabilin2, Angptl3 and IL6 for sinusoidal endothelial markers.  
 
These data suggests that hepatocytes soluble factors are able to promote and to maintain 
differentiation state of SECs . 
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Figure 7. Phenotypic and transcriptional analysis of MLECs 
 
A- Left: FACS analysis of MLECs maintained in MH-CM (A)and in endothelial instructive medium (A’’). We analysed a specific 
sinusoidal endothelial markers, such as LYVE1, MECA3; and endothelial markers, such as CD144, CD105 and CD31. In dot plot is 
reported the percentages of positive cells to each markers. Data suggesting as MLECs show sinusoidal endothelial features although 
are cultured for a long time in particular in presence of hepatocytes markers. 
B- Right: Transcriptional analysis of endothelial and sinusoidal endothelial markers on MLECs maintained in hepatocytes soluble 
factors or in endothelial soluble factors. The real-time PCR results were calculated by ΔΔCT Method. mRNA levels are relative to 
endogenous -actin.  
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5.5  MLECs forms sinusoids in Orthotopic Transplants   
 
To value in vivo the intrinsic capability to organization and  differentiation of SEC, MLECs 
EGFP+ cells were injected directly into the liver of untreated immuno-tollerant (CD1) mice 
at the first day after birth, through a percutaneous trans-abdominal puncture. Animals were 
sacrificed at various times and the peak of colonization was found around two month after 
cell transplantation. MLECs capitalizing on the differentiating and proliferative stimuli of 
the growing organ and in competition with endogenous cells suggesting a capability of 
MLECs to play a physiological role. 
MLECs EGFP+ were identified by EGFP and CD31 co-expression. EGFP+ cells are able to 
form  sinusoids, but also, a large vessels, as shown by Figure 9. 
 
Figure 9. Characterization of MLECs in orthotopic transplants. 
MLECs, previously genetically marked with a retroviral vector expressing GFP, were injected intrahepatically in CD1 newborn mice; two 
months after injection the livers were collected and immuno-stained. 
A- IF analysis shown that MLECS EGFP+ co-express sinusoidal endothelial markers, CD31 (red), and promote the interaction with 
endogenous sinusoidal endothelial cells.  
B- A particular of sinusoidal endothelial cells organization’s in vivo.  
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MLECs EGFP+ displays a physiological interaction with endogenous sinusoidal endothelial 
cells during liver growth.  
 
 
 
 
Figure 10. Orthotopic transplants.  
IF analysis shown that  MLECs  display  physiological interactions with endogenous cells, during the formation of sinusoids and large vessels. 
In figure A is noted a correct  cellular organization between  endogenous and exogenous SECs; it is observable the  co-expression of CD31 and 
EGFP in sinusoids near to a large vessels that express only CD31. 
In figure B is showed in  large vessels a cell contact between  MLECs and SECs, while sinusoids have co-expression of CD31 and EGFP. 
 
 
In particular, MLECs EGFP+ displays a physiological interaction with endogenous cells, as 
shown by pericyte localization near exogenous SECs (Figure 11). 
Taken together, these date indicated that SECs are able to promote cellular interplay 
between parenchymal and non-parenchymal cells also in vivo. 
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Figure 11. Orthotopic transplants.  
IF analysis shown that  MLECs  display  physiological interactions with endogenous cells, as shown by pericyte localization near exogenous 
MLECs. 
In figure A is noted a correct  cellular organization between  endogenous and exogenous SECs; it is observable the  co-expression of CD31 and 
EGFP in sinusoids near to a large vessels that express only CD31. 
In figure B is showed in  large vessels a cell contact between  MLECs and SECs, while sinusoids have co-expression of CD31 and EGFP. 
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Chapter 6: Discussion 
 
Liver is a prime example of the pivotal role played by cellular interplay in the organ 
functions. 
For years, investigators have developed culture models based on features of liver 
architecture to recapitulate the complex hepatocyte microenvironment.  These  features 
include extracellular matrix as found in the space of Disse, physicochemical stimuli 
imposed by sinusoidal blood flow, and cell–cell interactions present in the hepatic cord. 
Cell–cell interactions, both homotypic (hepatocyte–hepatocyte) and heterotypic 
(hepatocyte–non parenchymal cell), have been shown to improve viability and function. 
Restoration of hepatocyte interactions as in spheroidal aggregates promotes formation of 
bile canaliculi, gap junctions, tight junctions, and E-cadherins and stabilizes function. The 
heterotypic interactions in hepatocyte–non parenchymal co-cultures are thought to present a 
highly conserved signal that greatly augments liver-specific functions. Cell patterning 
methods have been used to study the “co-culture” effect by tightly controlling the amount of 
cell–cell interaction to identify specific signaling pathways.  
 
This study sought a first analysis of the cellular interactions underlying micro-
environmental controlled differentiation and functions of LSEC, HSCs and liver stem cells 
in physiologic and pathologic liver conditions. Here we present, in fact, a clonal cell line of 
resident liver stem cell (RLSC) (14) and clonal cell lines of sinusoidal endothelium as tools 
useful to improve knowledge of cell-cell dialogue in the liver and to approach liver tissue 
engineering.  
 
Regarding RLSCs, derived for murine liver explants and established in lines, we described 
the unexpected finding of their differentiation bi-potentiality that allows to obtain, from the 
same progenitor cell, epithelial and mesenchymal derivatives. 
With respect to the in vitro differentiation experiments, RLSC, previously shown in 
mitogenic media to differentiate coherently into hepatocytes, were found here, when 
cultured in low serum, to be also able of accomplishing an alternative mesenchymal 
differentiation path.  The tracking of the initial stages of differentiation highlighted as 
RLSCs spontaneously endeavor a mutually exclusive path that correlate with the loss of 
stem signature  (i.e. SCA1).  
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With respect to the in vivo differentiation experiments, RLSC, orthotopically transplantated 
in neonatal healthy growing liver, contribute to the formation of the adult organ  giving 
derivatives matching anatomical, morphological and molecular features of both epithelial 
and mesenchymal cells. In the mesenchymal progeny characterization, both 
immunophenotype and localization of RLSC derivatives are highly indicative of Hepatic 
Stellate Cells. The interesting evidences  that HSCs in adult liver may (also) arise from a 
precursor compartment  should be considered as a self-standing advance since, as yet, HSC 
precursors in adult animals have to be  identified. 
In heterotopic transplants again both RLSC mesenchymal and epithelial derivatives were 
found: mesenchymal cells expressed markers shared by HSCs (i.e. GFAP, alphaSMA);  
epithelial  derivatives were found mainly aggregated in tubular structures and expressing 
markers of endodermal precursors (i.e. EpCam, αFP), and only few cells weakly positive for 
markers of hepatocytes (i.e. Albumin). This indicates that in vivo only liver-specific cues 
allow driving the full liver-specific differentiation.  
Overall, RLSCs can conceivably be proposed as cells retaining features of the “meso-
endodermal” liver progenitor. To the best of our knowledge, this is the first time that a liver 
progenitor cell is described in vivo to differentiate toward a lineage with characteristics 
attributable to HSCs. In the frame of this last conclusion, further dedicated studies in 
disease-prone animals will clarify whether RLSC may contribute to the onset of liver 
fibrosis and whether the precursor compartment should be considered an additional 
therapeutic target.  
 
Regarding sinusoidal endothelium cells, here we present the isolation, the  establishment 
in clonal cell lines and the characterization of murine endothelial cells, MLECs.  
The major advancement coming from this part of my work is the set-up of culture 
conditions, based on the use of a hepatocyte conditioned medium, useful for the 
maintenance of liver specific  sinusoidal endothelium.  In fact, although  several endothelial 
cell lines from non-liver sources exist, a cellular model displaying the unique structures and 
functions of hepatic sinusoids, as well as the pathological changes they undergo during 
chronic liver disease, was lacking.  
We found that hepatocytes soluble factors support the liver endothelial cells proliferation, 
permits the retaining of the unique characteristics of SECs, primarily the trans-cytoplasmic 
fenestrations together with the expression of specific protein.  
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By the use of these particular  culture conditions we obtained stable endothelial cell lines  
able to form, heterotopically (when transplanted together with hepatocytes) and 
orthotopically, functional sinusoidal vessels. When transplanted in neonatal livers, in 
particular, MLECs forms sinusoids and large vessels, establish correct interactions with  
endogenous SECs, drive the architectural spatial organization of the hepatocyte into 
epithelial cord, interact with pericytes. 
 
In conclusion, we established in cell lines several liver histotypes, so realizing unique and 
high innovative cellular tools useful for the study of  cellular interplay in physiology and 
pathology; the improvement of protocols of liver tissue engineering. 
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